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CHAPTER I 
INTRODUCTION 
I.1. EUKARYOTIC TRANSCRIPTION 
In eukaryotes, transcription is driven by three distinct RNA polymerases: RNA 
polymerase I (RNAPI), RNA polymerase II (RNAPII), and RNA polymerase III (RNAPIII) 
[1]. Although possessing a similar structural design, they transcribe different species of 
RNA. RNAPI and RNAPIII transcribe genes encoding ribosomal RNA (rRNA), transfer 
RNA (tRNA), and small nuclear RNA (U6 snRNA), whereas RNAPII is responsible for 
the  transcription of the protein-coding genes, the majority of small nuclear RNAs 
(snRNAs), and small nucleolar RNAs (snoRNAs). In addition, RNAPII transcribes a wide 
range of RNA species with no apparent coding potential. These non-coding RNAs 
include small interfering RNAs (siRNAs), micro-RNAs (miRNAs), cryptic unstable 
transcripts (CUTs), stable unannotated transcripts (SUTs), Xrn1 stabilized transcripts 
(XUTs), meiotic unannotated transcripts (MUTs), and Ssu72-restricted transcripts 
(SRTs) ([2-8]. In addition, there are other RNAPII-transcribed non-coding RNA species 
that do not fall into any of the categories described above. The biological role of many of 
these non-coding RNAs is not yet clear [9]. 
I.2. RNA POLYMERASE II 
RNAPII is a large, multisubunit enzyme that is highly conserved from yeast to 
human. It has a molecular weight of ~0.5 MDa. It is composed of 12 subunits. The 
catalytic core of the enzyme is formed by 10 subunits; Rpb1, Rpb2, Rpb3, Rpb5, Rpb6, 
Rpb8, Rpb9, Rpb10, Rpb11 and Rpb12. The core enzyme can efficiently elongate 
transcripts, but is deficient in promoter-associated initiation and the termination 
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 of transcription. The dimer of Rpb4/Rpb7 associates with the core to make a form of 
enzyme that can accomplish all steps of transcription from initiation to termination.  The 
Rpb4/Rpb7 dimer is crucial for initiation as well as termination steps of transcription [10-
14]. The carboxy-terminal-domain (CTD) of the largest subunit of RNAPII (Rpb1) is 
critical for both transcription and cotranscriptional RNA processing. This CTD consists 
of tandem heptapeptide repeats of the sequence Y1S2P3T4S5P6S7. The number of 
repeats varies from 26 in yeast to 52 in mammalian systems. During the transcription 
cycle, the CTD is subjected to several post-transcriptional modifications that work as 
recognition marks for binding of the factors required for the execution of different steps 
of transcription [15].  On its own, RNAPII can unwind DNA, synthesize RNA, proofread 
the nascent transcript, and rewind DNA. It cannot, however, recognize the regulatory 
3 
 
 
 
elements located at the 5' and 3' ends of the gene, or respond to regulatory cues 
[16,17]. The recognition of regulatory elements and response to environmental cues 
requires a group of accessory factors.  
I.3. RNAPII TRANSCRIPTION CYCLE 
The transcription cycle of RNAPII can be divided into four major steps; initiation, 
elongation, termination and reinitiation [18] (Figure I.2).  These steps occur sequentially 
in a coordinated manner [12,18-20]. The transcription cycle starts with the binding of an 
activator to the upstream activating sequence (UAS) or enhancer element. The activator 
facilitates the recruitment of RNAPII and the general transcription factors (GTFs); TFIID, 
TFIIB, TFIIA, TFIIF, TFIIE and TFIIH, to the promoter to form a ~2 MDa pre-initiation 
complex (PIC). The PIC assembles in the following order; TFIID-TFIIB-TFIIA-RNAPII 
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and TFIIF-TFIIE-TFIIH (Figure I.1) [21-24]. The GTFs get recruited to the specific DNA 
sequences flanking the transcription start sites (TSSs) in the promoter region. These 
DNA elements are collectively called ‘Core Promoter Elements’ (CPEs), and include the 
TATA-box, the initiator (INR)-element, TFIIB-recognition elements (BRE), downstream 
promoter elements (DPE), and a variety of other gene specific elements. The 
combination of these regulatory elements is gene specific, and it seems that each 
promoter has a distinct architecture. The first promoter element identified was the 
TATA-box (TATAA) located ~25 bp upstream of the TSS. The general transcription 
factor that is recruited first on the promoter during the transcription cycle is TFIID. It is a 
megadalton complex containing the TATA-binding protein (TBP) and the TBP 
associated factors (TAFs). The binding of TBP to the TATA-box bends DNA in the 
promoter region. TBP may also be recruited on some promoters as a component of the 
SAGA complex. TFIID then interacts with the TFIIA via TAF40-TFIIA interaction, and 
helps stabilize TFIID-DNA interaction [16,25]. In the absence of a TATA-box, TFIID 
initiates PIC assembly by binding to the initiator (INR)-element and the DPE. The 
interaction of TFIID with INR-element and DPE is through TAFs [25,26]. The next 
general transcription factor to arrive on the promoter is TFIIB, which is recruited through 
its interaction with the BREu and BREd elements that flank the TATA-box. TFIIB binding 
results in the formation of a stable ternary complex (DNA-TFIID-TFIIB complex). The 
ternary complex is sufficient to facilitate the recruitment of RNAPII.  The interaction of 
the RNAPII with the ternary complex requires TFIIF [25]. The crystal structure has 
revealed that the N-terminal region of TFIIB has a loop structure, the “B-finger”, 
reaching into the active site in the cleft of the polymerase. The B-finger plays a very 
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critical role in start site selection by RNAPII. TFIIE and TFIIH are recruited next. TFIIH is 
a 12 subunit complex with a molecular weight of ~500 KD [27]. The helicase activity of 
TFIIH is required for promoter clearance. RNAPII and the above mentioned GTFs are 
able to direct accurate initiation of transcription from the promoter and establish a basal 
level of transcription. They, however, fail to respond to gene-specific activators. 
‘Mediator’ helps activator communicate with the general transcription machinery. 
Mediator is a ~1 MDa complex composed of more than 24 subunits. It works as a 
transducer of the regulatory information from activators/repressors to the PIC [28]. 
Considering its recently demonstrated role in basal transcription, Mediator is now 
considered one of the general transcription factors. 
I.3.1. INITIATION  
Initiation is an early step in the transcription cycle, and the one most targeted by 
the regulatory signals. The successful assembly of a functional PIC on the promoter 
region is a pre-requisite for the initiation of transcription. However, the mere formation of 
a PIC is not a guarantee for the successful initiation of transcription. For initiation to 
occur, the DNA bound by the active site of the polymerase has to unwind so that the 
single stranded region is exposed and can act as a template. This step results in the 
formation of a bubble at the TSS (-9 to +2), and an ‘open complex’ is formed.  The 
unwinding of DNA during bubble formation is an intrinsic activity of the polymerase. The 
maintenance of the bubble needs TFIIF, which binds to the non-template strand and 
assists in establishing the open promoter conformation. TFIIB has also been proposed 
to play a crucial role in this step [25,29]. After bubble formation, RNAPII initiates 
transcription. The fate of the initiation event depends on the length of the nascent 
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transcript [30]. Transcription starts with the repetitive synthesis and abortion of short 
transcripts. The transcripts of less than 5 nucleotides are often unstable and are 
frequently aborted. When the transcript length reaches 6 nucleotides, it starts clashing 
with the B-finger loop of TFIIB that is inserted into the RNA exit channel of the 
polymerase [29]. During the transition from initiation to elongation, the B-finger of TFIIB 
is pushed out of the RNA exit channel and the bubble collapses. The bubble collapse is 
facilitated by the helicase activity of the Ssl2 (XPB in higher eukaryotes) subunit of 
TFIIH that acts as a wrench to unwind the DNA downstream of the bubble. A recent 
report implicated TFIIH in the formation of the bubble as well [23]. 
In addition to the helicase activity, TFIIH possesses another enzymatic activity, 
the kinase activity.  The Kin28 (Cdk7 in mammals) subunit of TFIIH is the kinase 
specific for Ser-5 (Y1S2P3T4S5P6S7) of the CTD.  The Ser5- phosphorylated CTD acts as 
a loading dock for the capping enzyme [15]. The capping enzyme adds a 
methylguanosine cap to the 5' end of the nascent transcript as soon as it emerges from 
the RNAPII exit channel, which happens when the length of the transcript is 17-25 
nucleotides. The 25 nucleotide long capped transcript marks the end of initiation, and 
the beginning of the elongation step [31,32]. Up to this point, RNAPII is still tethered to 
the promoter-bound initiation complex. In order to escape from the promoter, RNAPII 
must sever its ties with the promoter-bound factors. The promoter escape/clearance 
requires both of the enzymatic activities of TFIIH [25,33]. Upon promoter clearance, a 
number of GTFs remain at the promoter, forming a reinitiation ‘scaffold’ [20,23,34]. The 
reinitiation scaffold consists of TFIID, TFIIA, TFIIE, TFIIH and Mediator. The scaffold 
serves as a launching pad for re-entry of RNAPII, TFIIB and TFIIF during subsequent 
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rounds of transcription. This facilitates faster reinitiation and increases transcription 
efficiency by bypassing the need for the de novo PIC assembly [20]. 
I.3.2. ELONGATION     
Soon after promoter clearance, RNAPII encounters a number of barriers, such as 
inhibitory factors, arrest sequences, and nucleosomes. In most of the eukaryotes, 
RNAPII pauses at ~50 bp from the TSS. This pausing could be a check point to allow 
time for the recruitment of the capping enzyme [35]. It is induced by two factors, DSIF 
(DRB-sensitive inducing factor) and NELF (Negative elongation factor). The pause is 
alleviated by the positive elongation factor P-TEFb (Ctk1/Bur1 in yeast) which mediates 
the phosphorylation of Ser2 of the CTD as well as DSIF and NELF thereby neutralizing 
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their inhibitory effect. Another common impediment for the elongating polymerase is 
offered by AT-rich sequences, where the polymerase backtracks and gets arrested due 
to the misalignment of the active site with the 3' end of the growing RNA chain.  This 
elongation arrest is overcome by TFIIS, which stimulates the 3' to 5' exonuclease 
activity of the backtracked polymerase, thereby aligning the active site with the 3' end of 
the growing RNA chain [36,37]. The elongating RNAPII also needs to overcome the 
nucleosomal barrier during elongation. At least three different types of activities help the 
polymerase get around the nucleosomal obstruction. These are ATP-dependent 
chromatin remodelers, histone chaperones and histone modifying enzymes. The ATP-
dependent chromatin remodelers like RSC and Chd1 modify chromatin using the 
energy of ATP hydrolysis, while histone modifying enzymes like Set, Set2 and HATs 
post-translationally modify the histone tails by adding a chemical group.   
I.3.3. TERMINATION 
There are two distinct, although coupled, events occurring at the end of each 
RNAPII transcriptional cycle: (1) the 3' end processing of the nascent transcript, and (2) 
termination of transcription (Figure I.3). 3' end processing is the endonucleolytic 
cleavage of RNA at the 3' end followed by the addition of about 50-60 adenine 
nucleotides (180-200 in higher eukaryotes) to the cleaved end. The polyadenylated 
transcript is then released from the template. The elongating polymerase may still keep 
on transcribing the template. The termination of transcription is not accomplished until 
the polymerase also dissociates from the template.  Thus, termination of transcription 
involves the release of transcript as well as the polymerase from the template [38]   
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Although the factors required for the 3' end processing of mRNA are relatively 
well characterized, a thorough understanding of the factors required for the termination 
of transcription has eluded us. The cleavage and polyadenylation of pre-mRNA is 
critical for cell growth and viability. It is a pre-requisite for transport of mRNA from the 
nucleus to the cytoplasm [39]. The polyadenylation confers stability to the transcript by 
preventing exonucleolytic cleavage of mRNA from the 3' end [40,41]. The 
polyadenylated transcripts are also a better substrate for translation by ribosomes [41]. 
3' end processing is often a pre-requisite for termination of transcription [42,43]. In fact, 
cleavage and polyadenylation are generally coupled to termination. The first clue in this 
regard came when it was shown that both processes are dependent upon the same 
DNA sequence elements at the 3' end of genes [44-49]. The interdependency of these 
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two events was further reinforced when it was found that a number of cleavage and 
polyadenylation factors are also required for termination [50-52].  
Termination is a crucial step in the eukaryotic transcription cycle. Efficient 
termination is essential for the maintenance of the overall integrity of the transcriptome 
[53]. It ensures that a pool of free polymerase molecules is available for reinitiation 
during subsequent rounds of transcription [54]. Termination also prevents transcription 
interference among neighboring genes [55,56]. In yeast, this is of particular significance 
due to the compact nature of the genome [57]. Furthermore, termination prevents 3' 
end-initiated antisense transcription that may interfere with the normal sense 
transcription [54]. In addition, proper termination prevents the synthesis of extended, 
nonfunctional RNAs [58].  
I.3.3.1 Cis-acting elements required for 3' end processing/termination  
Despite its overwhelming significance, termination is the least understood step of 
the eukaryotic transcription cycle [54]. The termination of transcription requires cis-
acting elements and trans-acting factors. Many of the factors required for termination 
are the same as required for 3' end processing of precursor mRNA. The 3' end 
processing is directed by the sequence elements embedded within the coding region 
and the 3' untranslated region (3'UTR) of the pre-mRNA [59] (Figure I.4). Disruption of 
these elements reduces the efficiency of 3' end processing of RNA [60]. The cis acting 
elements required for 3' end processing are quite similar in yeast and mammals 
(Figures I.4 and I.5). However, they exhibit major differences as well. In yeast, the 
analysis of the 3' end cis acting elements is complicated due to a high degree of 
variability and redundancy [59]. The poly(A) site, which is an important element required 
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for both 3' end processing and termination, is defined by four elements: the AU-rich 
efficiency element (EE), the A-rich positioning element (PE), the cleavage site [Y(A)n], 
and two U-rich elements flanking the cleavage site, namely, the upstream U-rich 
element (UUE) and  the downstream U-rich element (DUE) [61,62]. In contrast, the 
poly(A) site in mammals contains three primary and two auxiliary elements that 
determine and regulate the 3' end processing reaction. The three primary elements are 
the polyadenylation signal (PAS), AAUAAA, the cleavage site, CA, and the downstream 
element (DSE), mainly composed of G/U rich region. The two auxiliary elements are 
upstream U-rich element and the downstream G-rich element [61,62]. 
The cis-acting elements required for termination of transcription are not as well 
characterized as the ones required for the 3' end processing. However, some studies 
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have uncovered some sequences involved specifically in termination. First, a study 
done by the Sherman lab revealed a consensus element (TAG…TAGT…TTT) that is 
present in about 14 genes as a key termination signal [47,63]. Second, it has been 
demonstrated that a sequence downstream of the poly(A) site in the gastrin gene can 
cause transcription termination regardless of the presence of the poly(A) site [64,65]. 
Third, a sequence in the adenovirus genome called CCAAT-box was shown to be 
necessary for termination [66]. In general, 3' end processing and termination are 
thought to be the function of both a functional poly(A) signal and a downstream RNAPII 
pausing site [42,64,67,68]. In general, a poly(A) site is required for the termination of 
transcription of most RNAPII-transcribed genes. It has been reported that termination 
does not occur at a specific site or distance from the poly(A) site, but takes place at 
variable distances from the poly(A) site (about 100-150 bp downstream of the poly(A) 
site in yeast, and from a few bases to several kilo bases from the AAUAAA site in 
mammals) [42,63,64,69,70].  
I.3.3.2. Trans-acting factors required for 3'end processing/termination  
Although the reactions taking place at the 3` end of a gene are seemingly simple, 
a megadalton complex is required to execute these reactions (Figures I.4 and I.5). The 
CFI (Cleavage Factor I), CPF (Cleavage Polyadenylation Factor), and Rat I complexes 
are required for both cleavage-polyadenylation as well as termination of transcription In 
budding yeast [71]. These complexes together are made up of more than 23 proteins 
[61]. The CFI complex is composed of five subunits; Rna15, Rna14, Pcf11, Hrp1, and 
Clp1 [72]. The chromatographic analysis revealed that CFI complex can be further 
separated into the CFIA (Rna14, Rna15, Pcf11 and Clp1) and CFIB (Hrp1) 
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subcomplexes [59,73]. The CPF complex consists of seven subunits organized in two 
subcomplexes; PFI (Polyadenylation Factor 1) and CFII (Cleavage Factor II). The PFI 
subcomplex contains three subunits, Fip1, Yth1 and Pfs2, while the CFII subcomplex 
contains four subunits, Pta1, Yhh1, Ydh1, and Ysh1. In addition to these two 
subcomplexes, CPF contains other subunits that are not part of either of these 
subcomplexes. These are Pap1, Pti1, Ssu72, Glc7, Syc1, Swd2 and Mpe1 [59,61,74]. 
In vitro studies showed that the cleavage reaction requires CFIA, CFIB and CFII, while 
polyadenylation requires CPF, CFIA, CFIB and Pap1. The third complex, the Rat1 
complex, is a dedicated termination complex and contains three subunits, Rat1, Rtt103, 
and Rai1 [75]. As described earlier, the Rat1 subunit of this complex possesses the 5' to 
3' exoribonuclease activity.  
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 The 3' end processing/termination machineries in yeast and mammals exhibit a 
lot of similarities (Figures I.4 and I.5) [61,62]. The mammalian machinery includes 
several complexes namely, Cleavage and Polyadenylation Specificity Factor (CPSF), 
Cleavage Stimulatory Factor (CstF), Cleavage Factor I (CF Im), and Cleavage Factor II 
(CF IIm) [61,62,71]. In addition to these complexes, poly(A) polymerase (PAP1), Poly(A) 
Binding Proteins (PABP), symplekin and the CTD of RNAPII are also needed for 3' end 
processing (Figure I.5.) [61,62]. Many of the yeast subunits have homologues in 
mammals. For example, subunits of the yeast CPF subunits are homologous to the 
CPSF subunits, and yeast CFI complex exhibits homology with mammalian CstF 
complex. In addition, Rat1 and Rai1 subunits of yeast Rat1 complex are homologous to 
mammalian Xrn2 and Dom3z subunits respectively [75]. Despite these homologies, 
there exist significant differences between the yeast and mammalian complexes. The 
yeast termination factors mentioned above are those required for the termination of 
transcription of a majority of mRNA transcripts. The termination of transcription of 
snRNAs, snoRNAs, CUTs and short mRNAs in yeast occurs through a distinctive 
pathway that requires a different set of termination factors.  The core factors required in 
this pathway are Nrd1, Nab3, and Sen1. In addition to these factors, termination of at 
least some of the non-coding RNA species also requires mRNA 3' end 
processing/termination factors [75]. 
I.3.3.3. CLEVAGE FACTOR I COMPLEX (CFI)  
The focus of this study is the CFI complex. It is comprised of five subunits 
organized into two subcomplexes, CFIA and CFIB [72,73]. The CFI complex can be 
assembled in vitro from purified, recombinant components, which suggests that the 
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 assembly may not be dependent on other cellular factors. The CFIA subcomplex is 
composed of two subunits each of Rna14 and Rna15, and one subunit each of Pcf11 
and Clp1 [76,77], while CFIB subcomplex is constituted of a single protein, Hrp1 (Figure 
I.6). None of the five subunits of the CFI complex possess endoribonuclease activity. 
The CFI complex has been implicated both in 3' end processing of nascent mRNA as 
well as termination of transcription.  The precise role of the CFI complex in termination 
and RNA processing is not clear yet. It has been suggested that the function of the CFI 
complex is to facilitate the recruitment of the CPF complex, which then executes both 3' 
end processing and the termination step of transcription [78]. The CFI complex has also 
been implicated in the export of mRNA from the nucleus to the cytoplasm [79-81]. The 
Hrp1 and Rna15 subunits of CFI complex have RNA recognition motifs (RRM), which 
help them to bind the nascent mRNA and position the processing/termination machinery 
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to the 3' end of transcribing RNA. The Pcf11 subunit has a CTD interaction domain 
(CID) that interacts preferentially with the Ser2-phosphorylated form of the CTD. Pcf11 
is one of the best studied subunits of the CFI complex. It has been implicated both in 
poly(A)-dependent and poly(A)-independent termination pathways [48,82-84]. It is the 
only subunit that makes direct contact with three other CFI subunits, namely Rna14, 
Rna15, and Clp1. It has also been found to interact with the Pta1, Ssu72, Ysh1, Cft1, 
and Cft2 subunits of CPF complex, although a direct binding to these factors has not 
been proved [85]. The ability of Pcf11 to interact with the CTD suggests that it may be 
the factor that facilitates the CTD-dependent recruitment of the CFI and CPF complexes 
to the 3' end of RNA.  
In addition to Pcf11, two other components of the CFI complex, Rna14 and 
Rna15, have also been the focus of intense investigation. Rna15 recognizes the A-rich 
EE in the nascent transcript through its RRM. Dimerization of Rna14 with Rna15 helps 
guide Rna15 to the EE because Rna14 works as a bridge between Rna15 and Hrp1. 
The mammalian counterparts of Rna14 and Rna15, called CstF64 and CstF77, also 
form a dimer [86].  
Of all the CFI subunits, Clp1 is the least explored. Clp1 was first reported as a 
subunit of CFI complex in 1997 by Walter Keller’s laboratory [87]. However, it was not 
the focus of intense investigation until recently. This could be attributed, in part, to the 
non-availability of reliable conditional mutants for this subunit [76]. Clp1 has been 
conserved during evolution from yeast to humans. Yeast Clp1 shares 23% identity with 
its human counterpart [61,88]. Clp1 possess a large central domain through which it 
interacts with a number of 3' end processing/termination factors. The small N-terminal 
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and C-terminal domains are crucial for cell viability [89]. The central domain of Clp1 
contains an evolutionarily conserved ATP binding motif called ‘Walker A motif’ (Figure 
I.7) [76]. While the human Clp1 was shown to have an ATPase activity, biochemical 
assays demonstrated that yeast Clp1 lacks such activity at least in vitro [90]. The 
precise function of the ATP-binding motif of yeast Clp1 and its effect on cell viability is 
controversial [89,91]. Clp1 interacts with a number of factors belonging to both CFI and 
CPF complexes through its N-terminal and central domains. It interacts with Pta1, Cft1, 
Pfs2, and Pcf11 via its central domain and with Ysh1 and Ssu72 via the N-terminus 
domain. It has been shown to play a central role in the assembly of the CFIA complex 
[89,92]. The crucial role of Clp1 in the assembly of the CFIA complex, the central 
position of Clp1p in the processing/termination machinery, and its multiple interactions 
with other 3' end processing/termination factors makes it a suitable factor for mediating 
the interaction of the CFI and CPF complexes [89,91,92]. In vitro studies have revealed 
a role for Clp1 in both the cleavage and polyadenylation steps of 3' end processing 
[72,89]. In addition, in vivo analysis showed that Clp1 plays a role in termination of 
transcription of snoRNAs and CUTs [92].  However, the precise function for Clp1 in the 
termination of protein coding genes has not been fully addressed yet in vivo. Apart from 
the five proteins making the CFI complex, another protein, poly(A) polymerase 1 (Pap1),  
has been found to be functionally related to this complex [38]. Additionally, studies from 
our lab found Pap1 in a complex with CFI and TFIIB [93]. Pap1 is an authentic 
component of the CPF complex. It is an essential 3' end processing enzyme that is 
required along with CFI, PFI and PFII for the addition of poly(A) tail to the 3'-OH group 
generated after the cleavage of the nascent transcript [38,94]. In the absence of CFI, 
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PFI and PFII, Pap1 can add a poly(A) tail nonspecifically to any RNA which indicates 
that CFI and PFII confer substrate specificity to Pap1p.  
I.3.3.4. Pathways for the termination of transcription by RNAPII 
Termination of transcription occurs through at least two different pathways; a 
poly(A)-dependent pathway, and a poly(A)-independent pathway. There are two models 
explaining the termination of transcription by poly(A)-dependent pathway; the ‘allosteric 
model’ and the ‘torpedo model’ [42,44,95,96]. Both models connect termination directly 
or indirectly to poly(A)-dependent 3' end processing. The allosteric model states that 
termination is the consequence of a conformational change in the elongation complex 
triggered by transcription through the poly(A) site.  The recruitment of negative 
elongation factors or the release of anti-termination factors may contribute to the 
conformational changes in the elongation complex. The net result is the destabilization 
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of the elongation complex, thereby facilitating termination [54,97]. The torpedo model, 
on the other hand, suggests that the termination of transcription by RNAPII occurs in a 
manner similar to rho-dependent termination in bacteria. The endonucleolytic cleavage 
of the nascent mRNA at the poly(A) site results in polyadenylation followed by the 
release of processed mRNA.  The downstream cleavage product ,RNA with an 
uncapped 5' end, however, is still attached to the elongating polymerase. The torpedo 
model suggests the degradation of this downstream cleavage product is critical for 
termination of transcription. Rat1 (Xrn2 in mammals) is an exonuclease with 5' to 3' 
exoribonuclease activity. Rat1 binds to the uncapped 5'-monophosphate end of the 
elongating RNA and starts cleaving the transcript from 5' to 3' end until it catches up 
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with the advancing polymerase. The polymerase then dissociates from the template in a 
manner that is still not completely understood [98,99]. There is experimental evidence in 
support of both models. The actual method of termination may be a ‘hybrid’ of the two 
proposed models [82,100]. The poly(A)-independent termination pathway, which has 
been shown to operate in budding yeast, is dependent on Sen1. The Sen1-dependent 
pathway has been implicated in termination of transcription of small stable non-coding 
RNAs (sn/snoRNAs), and cryptic unstable transcripts (CUTs) [53,54]. It is also involved 
in the termination of short protein coding genes [101,102]. This termination pathway 
requires the function of exosome-TRAMP complex, which utilizes its exonuclease 
activity to either trim the snRNA/snoRNA transcript to the mature stable RNA or to 
terminate and degrade the CUTs after endoribonucleolytic cleavage [53,64,75]. 
The transcription cycle of RNA polymerase II can be divided into a number of 
discreet steps. These are the assembly of the preinitiation complex, initiation, promoter 
clearance, elongation and termination. A well orchestrated coordinated execution of 
these steps is essential for completion of the transcription cycle. The steps of 
transcription are interlinked, and affect each other. It was known for a long time that 
initiation affects elongation, and elongation is important for termination. It was, however, 
not appreciated that termination affects reinitiation of the next round of transcription. 
Recent evidence suggests that a network of intricate interactions exists between the 
initiation and termination steps of transcription (Figuer I.8).  
 The experimental evidence that suggest a termination-reinitiation link can be 
divided into four broad categories.  First, genetic screens revealed multiple interactions 
between the initiation and termination factors [103-118]. The most well studied of these 
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interactions is that of TFIIB with Ssu72.  Second, a number of studies using 
independent experimental approaches have found a network of physical interactions 
between initiation and termination factors [74,93,107,112,114,115,117-131]. Many of 
these physical interactions were also observed in the genetic screens. Third, 
crosslinking studies have found a number of initiation and termination factors occupying 
both the ends of genes [67,93,120,132-136]. (Figure I.9). Fourth, Chromosome 
Conformation Capture (CCC) analysis of multiple genes has revealed that the promoter 
and the terminator regions of genes are juxtaposed during transcription.  Such 
promoter-terminator interactions result in the formation of a looped gene conformation 
[7,93,120,132,137-150]. These findings strongly suggest a crosstalk of the termination 
and reinitiation steps during the transcription cycle. Termination of a round of 
transcription is therefore not the end of the transcription cycle, but rather the beginning 
of the next round of transcription.  
I.3.4. REINITIATION  
Following the initial round of transcription, the chromatin template is utilized by 
multiple reinitiation events to make multiple copies of the transcript from the same gene. 
The studies suggest that the first and the subsequent rounds of transcription are not 
identical, as many steps required for de novo initiation are bypassed during reinitiation. 
Reinitiation is crucial for the persistence of an activated state through multiple 
transcription cycles, and is therefore a significant determinant of the level of RNA in the 
cell. Despite its critical role, reinitiation is still a poorly characterized aspect of the 
transcription cycle. During the first round of transcription, the general transcription 
factors and RNAPII assemble on the promoter, forming a preinitiation complex (PIC). 
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Following the initiation of transcription, most of these factors are left behind on the 
promoter, forming a ‘scaffold’ that serves as the entry point for RNAPII during reinitiation 
[34]. Since multiple steps involving the recruitment of GTFs are bypassed during the 
second and subsequent rounds of transcription, reinitiation is always faster than 
initiation. Reinitiation efficiency can be augmented further if RNAPII is somehow directly 
transferred from the terminator to the promoter without being released from the template 
[151]. This hyperprocessive reinitiation could potentially boost the transcription rate by 
many fold.  
The reinitiation strategies described above are supported by several studies that 
showed that the number of RNA polymerase molecules in eukaryotic cells does not 
considerably exceed the number of active transcriptional units at a given time [152-156]. 
These findings argue against the presence of a large pool of free polymerase molecules 
available for de novo initiation events. Recent studies strongly suggest that the recycling 
of RNA polymerase is facilitated by the interactions of the initiation and termination 
machineries [132,137]. These interactions result in the formation of dynamic structures 
termed ‘gene loops’ that may facilitate RNAPII recycling through multiple transcription 
events [157].  
I.4. GENE LOOPING  
Several findings have revealed cross-talk between the promoter and the 
terminator regions of several eukaryotic genes during transcription (Figure I.10) 
[137,140,147,149,150]. The interaction of the promoter and terminator regions of a gene 
resulting in the formation of a looped conformation is referred to as gene looping 
[132,137,139]. First reported in yeast, it was later discovered in higher eukaryotes as 
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well [138,140-142,145,147-150]. Gene loops have been observed in mammalian 
systems for a number of genes, including the HIV proviral gene, BRCA1, CD68, COX2 
and MMP13 genes [138,140-142]. The promoter and 3′ terminal regions of the 
Progesterone Receptor (PR) coding gene were also found to be in close proximity, and 
RNAi machinery was implicated in formation of this gene loop [145]. How RNAi 
machinery facilitates looping of PR gene needs further investigation. Type II collagen 
coding gene (Col2a1), mainly expressed in chondrocytes, has also been shown to form 
a loop between the 3' UTR and the promoter [147]. Since an enhancer element is 
located in the 3' UTR of Col2a1, it is not clear whether this gene loop is due to the 
promoter-terminator interaction or the enhancer-promoter interaction. In addition, the 
optimal expression of the RARβ2 gene requires the formation of a gene loop [148].  The 
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gene looping here required the nucleotide excision repair (NER) factors. Apart from 
yeast and mammalian systems, gene looping has also been found in Drosophila 
melanogaster, wherein the polo gene was found to form a TFIIB-dependent gene loop 
in a manner reminiscent of that in yeast [149]. Last but not least, gene looping was 
recently demonstrated in plants for the floral repressor gene FLC. [150]. Gene looping 
may be a general, possibly ubiquitous, transcriptional regulatory mechanism in 
eukaryotic systems.  
Although the exact biological role of gene looping is not yet clear, it has been 
implicated in a variety of cellular functions including activation of transcription, 
repression of transcription, transcription memory, termination of transcription, 
directionality of promoter-initiated transcription and intron-mediated enhancement of 
transcription.  One potential role of gene looping that is conserved across a spectrum of 
eukaryotic systems is the enhancement of transcription. The transcriptional activation of 
genes have been found to coincide with the formation of a looped architecture in yeast, 
HIV provirus, mammalian systems, flies and plants [120,132,137,139,140,142-
144,147,150]. In budding yeast, it was demonstrated that the enhanced transcription 
was compromised in a looping defective strain [93]. In other organisms, however, it was 
not clear if transcriptional activation was the cause or the effect of gene looping. Further 
studies are needed to elucidate the role of gene looping in transcriptional stimulation. In 
yeast, it has been shown that gene looping accompanies activator-dependent 
transcription [120,143,144]. In the absence of gene looping, the kinetics of activator-
dependent transcription exhibited a lag phase [143,144]. It has been proposed that the 
gene loop confers a sort of transcriptional memory to the gene [143,144,158].  Gene 
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looping has also been shown to play a crucial role in the Intron-Mediated Enhancement 
(IME) of transcription [159].  Introns fail to enhance transcription of a gene in the 
absence of gene looping, thereby suggesting that it is not the intron-facilitated splicing 
but intron-dependent gene looping that was responsible for activation of the gene. Gene 
looping does not always lead to activation of the gene. The looping of the mammalian 
BRCA1 gene coincided with the repression of the gene in a transcription-dependent 
manner [141]. In Drosophila, gene looping was found to play a role in the termination of 
transcription and in coordinating the expression of tandem genes [149]. The 
transcription of Drosophila polo-snap tandem genes is negatively correlated. When polo 
is transcribed it forms a loop and this loop aids in keeping the downstream gene, snap, 
in a repressed state by masking its promoter by proteins involved in the polo loop 
formation. Consequently, the loss of polo gene looping exposes snap promoter 
elements, which leads to snap transcription.  
Last but not least, gene looping was recently implicated in conferring 
directionality to promoter-associated transcription. It was a long standing question why 
the promoter-bound polymerase tends to move in only one direction resulting in sense 
transcription. A recent study suggests that it is gene looping that prevents polymerase 
from transcribing in anti-sense direction [7]. Thus, gene looping seems to play different 
regulatory roles in different cellular contexts.  
Accordingly, our hypothesis is that gene looping facilitates rapid reinitiation 
events which increase the overall efficiency of transcription. Gene looping might 
execute this task by coupling termination to reinitiation. This coupling might result in a 
direct recycling of RNAPII from the terminator to the promoter; bypassing the rate 
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limiting step of de-novo RNAPII recruitment to the promoter. Transcriptional activation 
via coupling termination to reinitiation has been demonstrated for RNAPIII, RNAPI, 
mitochondrial RNA polymerase and archael polymerase [151,160-163]. There is some 
evidence indicating that a similar connection between termination and initiation exists 
during the RNAPII transcription cycle [164]. How termination was linked to initiation was, 
however, not clear in this study. The focus of this investigation is whether the 
termination-coupled reinitiation of transcription is dependent on gene looping. Gene 
looping-mediated enhancement of transcription may be through termination-reinitiation 
coupling. Recent evidence suggests that gene looping may also enhance transcription 
of a gene by conferring directionality to otherwise intrinsically bidirectional eukaryotic 
promoters [7]. Thus, gene looping mediated transcriptional activation may be the 
consequence of its effect on both termination-coupled reinitiation as well as promoter 
directionality.  
Given its occurrence in several diverse systems such as yeast, plants, flies and 
mammals, and its involvement in different transcriptional regulatory contexts, elucidating 
the mechanism and the role of gene looping will add to our understanding of how a cell 
can program a rapid response to environmental and developmental signals.  
I.5. DIVERGENT TRANSCRIPTION 
The methodological breakthroughs in genomewide transcriptome profiling 
analyses such as high resolution strand-specific tiling arrays, strand-specific global run 
on, and RNA-Seq combined with advanced high-throughput sequencing approaches, 
revealed the bidirectional nature of the promoters of eukaryotic RNAPII transcribed 
genes in species as diverse as yeast and mammals [2,3,70,165-169]. Promoter 
27 
 
 
 
bidirectionality results in transcription happening divergently from the promoter region of 
RNAPII-transcribed genes. The high prevalence of divergent transcription supports the 
proposal of them having a role in transcriptional regulation. 
In yeast, single gene as well as genomewide studies revealed the presence and 
prevalence of bidirectional promoters [3,168]. Promoter bidirectionality has been found 
to be the major source of the non-coding RNA (ncRNA) species called CUTs (cryptic 
unstable transcripts) [170,171]. CUTs are a principal category of RNAPII transcripts that 
are highly unstable due to RNA surveillance pathways in the cell, which explains their 
escape from detection in genomic assays. Immediately after synthesis, CUTs are 
targeted for degradation by the Nrd1-TRAMP-exosome complexes [4,170,172]. 
Accordingly, their detection was possible only when these surveillance mechanisms are 
compromised. Genome-wide studies utilizing different approaches have revealed that 
the CUTs are generally 200-600 nucleotides long and have heterogeneous 3` ends.  
They generally exist in low copy numbers, but are widespread within a cell. They 
originate predominantly from the nucleosome free regions (NFRs) that are the hallmark 
of most eukaryotic promoters. Although divergent transcription can happen as a 
consequence of the inherent nucleosome free nature of promoter regions which result in 
a chromatin architecture permissive for transcription, some evidence suggests that 
transcription contributes to formation of NFRs [2].  
ChIP-Seq studies revealed enrichment of the chromatin marks for transcription 
initiation like H3K4me2, H3K4me3 and H3 and H4 acetylation, at the bidirectional 
promoters. The H3K79me3, H3K36me3 and H2B ubiquitination elongation marks, 
however, are found only downstream of the promoter in the sense direction 
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[70,165,173-175]. The lack of elongation marks in the antisense direction suggests that, 
although initiation occurs in both directions, elongation occurs exclusively in the sense 
direction.  
I.5.1. TRANSCRIPTIONAL TERMINATION OF CUTs  
RNAPII transcribes many different classes of ncRNAs including TSSa-RNAs, 
siRNA, miRNA, SUTs, XUTs, CUTs, snoRNA, snRNA, SRTs, and MUTs [2-7]. 
Transcription termination of SUTs and XUTs is believed to involve the poly(A)-site 
(PAS) dependent pathway  [5,176,177]. In contrast, termination of CUTs, snRNA, 
snoRNA occurs through the Nrd1-dependent pathway [2,4,92,178,179]. Although the 
CPF and CFI complexes are integral components of the PAS-dependent termination 
pathway, recent evidence suggests their involvement in the Nrd1-dependent pathway 
as well [179]. The mechanism by which these three complexes act collectively to 
terminate the transcription of non-coding RNAs is not clear yet. Depletion of Clp1, a 
component of the CFI complex, resulted in defective transcription of all analyzed 
RNAPII transcribed genes including some CUTs ([92]. Whether the CFI and CPF 
complexes are generally required for the termination of CUTs needs further 
investigation [83,92,116,136,178,180-183].  
There are some observations that support a potential role for CFI and CPF in 
terminating the promoter-associated anti-sense transcripts (CUTs). First, a number of 
studies revealed the presence of components of the CFI and CPF complexes and their 
mammalian counterparts, CPSF and CstF, in the vicinity of the promoter regions 
[67,93,132-136,184]. Second, two recent studies independently reported the presence 
of functional PASs near the promoter region [184,185]. Third, a number of studies 
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demonstrated a role for the components of the CFI complex in termination of some 
CUTs. Fourth, there are some indications that components the CFI and CPF complexes 
are required for transcriptional directionality.  Taken together, these observations 
strongly suggest that the CFI and CPF complexes are involved in the termination of the 
promoter-initiated anti-sense transcripts, thereby restricting their elongation and 
providing directionality to the bidirectional eukaryotic promoters.  
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        CHAPTER II 
ROLE OF CFIB AND POLY(A) POLYMERASE (PAP1) IN TRANSCRIPTION AND 
GENE LOOPING 
II.1. ABSTRACT 
During transcriptional activation of a gene, the promoter and terminator regions 
of the gene physically interact with each other to form a looped structure. We have 
earlier demonstrated that this topology is formed by the interaction of the initiation and 
the termination machineries occupying the distal ends of a gene. We further found the 
general transcription factor TFIIB, the CFI subunits and the poly(A) polymerase (Pap1) 
exist in one megacomplex called ‘holo-TFIIB complex’ [93]. Earlier we examined the 
role of three CFIA subunits namely, Rna15, Rna14, and Pcf11 in promoter localization 
and gene looping [93,120]. Here, we extend this investigation to assess the role of the 
remaining CFI subunit Hrp1, which is generally referred to as the CFIB complex, as well 
as poly(A) polymerase (Pap1) in gene loop formation and other aspects of transcription. 
We found both Hrp1 and Pap1 crosslinked to the promoter as well as the terminator 
regions of a transcriptionally active gene. Utilizing the temperature sensitive mutants of 
Hrp1 and Pap1, we carried out ChIP (Chromatin Immunoprecipitation) and 
Chromosome Conformation Capture (CCC) analysis to determine the role of these 
factors in gene loop formation. Our results suggest that Pap1, just like CFIA subunits, 
contacts the 5' end of a gene. Since the presence of Pap1 at the distal ends coincided 
with gene looping, and looping was abolished in a mutant of Pap1, we conclude that 
Pap1 is required for gene looping. Hrp1 also crosslinks to the promoter end of a gene, 
but its role in gene loop formation needs further investigation.  
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II.2. INTRODUCTION 
The role of the CFI complex and poly(A) polymerase in 3` end processing and 
termination has been the focus of intense investigation [38,93]. The role of four of the 
five subunits forming CFI complex, Rna14, Rna15, Pcf11 and Hrp1 in RNA processing 
and the termination of transcription is well established [48,72,186]. The function of Pap1 
in the polyadenylation of mRNA has also been unequivocally demonstrated [48,187]. 
The CFI subunits Rna14, Rna15 and Pcf11 were found occupying the distal ends of a 
gene during transcriptionally activated state of a gene [93,120]. Accordingly, Rna14, 
Rna15, Pcf11 were found essential for gene looping [93,120]. The function of the 
remaining CFI subunits, Hrp1 and ClpI, as well as Pap1 in termination and gene 
looping, however, remained unclear. The role of Hrp1 and Clp1 as well as Pap1 in gene 
looping and aspects of transcription will be the subject of this and the following 
chapters. This chapter focuses on the role of Hrp1 and Pap1, whereas the role of Clp1 
will be the subject of the next chapter (Chapter III). 
Hrp1 is a heterogeneous ribonucleoprotein that binds the positioning element 
(PE) in the poly(A)-site through two internal RNA recognition motifs (RRMs) [188,189]. 
Hrp1 is a 73 KDa protein that was initially discovered as a suppressor of a temperature-
sensitive mutant of NPL3, which is an RNA export protein [81,190]. This suggested a 
possible role of Hrp1 in mRNA nuclear export. The role of Hrp1 in RNA transport gained 
further support when it was found shuttling between the nucleus and the cytoplasm 
[186]. Chromatographic analysis found Hrp1 in the fraction containing RNA processing 
factor CFIB [73,190]. Later on, the CFIB RNA processing function was assigned to Hrp1 
[186]. Hrp1 does not have a homolog in higher eukaryotes despite its essential role in 
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both cleavage and polyadenylation reactions in budding yeast [61,62,186]. In the 
context of its function as a 3' end processing factor, Hrp1 was found to bind to the PE 
and facilitate the correct positioning of the CFI complex on the nascent mRNA 
transcript. Both in vivo and in vitro studies have confirmed its function in cleavage as 
well as polyadenylation reactions [72,189]. The involvement of Hrp1 in gene loop 
formation however remains to be elucidated.     
Pap1p is an essential and highly conserved protein required for the addition of 
the poly(A) tail to the 3´ end of mRNA [191-193]. In principle, Pap1 has a nonspecific 
polyadenylation activity, and can polyadenylate any RNA substrate in vitro. Its mRNA 
specificity in vivo is conferred by the CFI and CPF 3' end processing complexes. The 
identity of Pap1 as the poly(A) polymerase enzyme was determined twenty years after 
finding the polyadenylation activity in yeast cell extracts[191,193]. Pap1p was found 
dispensable for the mRNA cleavage and the termination steps, but essential for the 
polyadenylation reaction [48,187]. Although, Pap1 is a component of the CPF complex, 
it has also been found associated with the CFI complex [38,93]. The role of Pap1 in 
gene looping has not been tested.  
Using temperature sensitive mutants, we found that Pap1 is required for gene 
looping of INO1 or MET16 while Hrp1 is not. However, both the factors crosslinked to 
the 5' end of the two genes. These results strongly suggest a role for pap1 in gene 
looping in budding yeast.   
II.3. RESULTS 
II.3.1. Role of Hrp1 and Pap1 in transcription of MET16 and INO1  
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To have an insight into the physiological function of Hrp1 and Pap1 in 
transcription and associated gene architecture, we used the temperature-sensitive 
mutants of Hrp1 and pap1 called hrp1-5 and pap1-1 respectively.  hrp1-5 carries a point 
mutation in the first RRM of Hrp1. The length of the poly(A) tail in this mutant is severely 
affected. The length of poly(A) tails was decreased in the hrp1-5 mutant strain [186]. 
pap1-1 mutant was kindly provided by Dr. Claire Moore and has been described in[187]. 
Both the mutant strains grow well at 25°C (permissive temperature), but stop growing 
following the transfer of cells to 37°C (non-permissive temperature). 
To determine the effect of these mutations on transcription and gene looping we 
used MET16 and INO1 genes. MET16 and INO1 are involved in the biosynthesis of 
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methionine and inositol respectively [194,195]. We have previously used these two 
genes successfully in our analysis for a number of reasons. First, transcription of both 
these genes can be easily regulated by simply changing the growth medium. The 
transcription of MET16 and INO1 is activated in the absence of methionine and inositol 
respectively. Second, their transcription is well understood, and their transcription 
activators are well characterized. Third, their size and restriction site locations makes 
them a suitable candidate for performing CCC analysis.  
To assess the effect of the mutant alleles, hrp1-5 and pap1-1, on the steady state 
transcription level of MET16 and INO1 under their different transcriptional states, we 
carried out RT-PCR analysis of MET16 and INO1 under activation conditiones in the 
wild type and the mutant strains. RT-PCR analysis revealed only a very minor decrease 
in RNA levels of either MET16 or INO1 in hrp1-5 cells following the temperature shift to 
37°C (Figure II.1, B and F; lane 2; and panels C and G, gray bars). In contrast, pap1-1 
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cells showed a three to five fold decrease in the mRNA levels of the two genes upon 
shifting of cells to the non-permissive temperature (Figure II.1, B and F; lane 2; and  
panels D and H, gray bars). No such decrease in the transcript level of genes was 
observed in the isogenic wild type strain at 37°C (Figure II.1, B and F; lane 2). These 
results suggest that Pap1 is required for the optimal transcription of MET16 
and INO1 while Hrp1 is not. 
Given the previously documented defect in the length of the poly(A) tail in hrp1-5  
mutant [186], our RT-PCR results were surprising. To determine whether a longer 
deactivation time is needed to see the expected effect on the steady state transcript 
level of these genes, we performed a deactivation time course for hrp1-5. RT-PCR 
analysis of INO1 was performed in hrp1-5 and the isogenic wild type cells induced at 
25°C or shifted to 37°C for 1, 2, and 3  hours (Figure II.2, Lanes 4, 5 and 6). A similar 
deactivation time course was performed for the rna14-1 strain as a positive control. As 
expected, the rna14-1 mutant displayed a dramatic decrease in the transcript level of 
INO1 upon shifting of cells to the elevated temperature for 3 hours. No such decrease in 
the RNA level was observed in hrp1-5 even after 3 hours of deactivation.  
II.3.2. Effect of pap1-1 and hrp1-5 mutants on gene looping 
Using the CCC approach, we have previously demonstrated the interaction of the 
promoter regions of MET16 and INO1 with their terminator sites in a transcription 
dependent manner [93,120]. Using this approach, we demonstrated the requirement of 
the Rna15, Rna14 and Pcf11 components of CFI complex in gene looping. In this 
approach, a PCR product obtained using divergent primers P1 and T1 is taken as a 
measure of gene looping (Figure II.3, A and E). A PCR product obtained using the F1 
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and R1 primers, a region lacking a restriction site, is taken as a control (Figure II.3, A 
and E).  
To examine the roles of Hrp1 and Pap1 in gene looping, CCC analysis was 
carried out for MET16 and INO1 under induced conditions in hrp1-5 and pap1-1 strains 
in the cells grown at the permissive and the non-permissive temperatures. A distinct P1-
T1 PCR signal was obtained for both MET16 and INO1 when pap1-1 cells were grown 
at 25°C (Figure II.3, B and F, lane 1; and panels D and H, gray bars). Upon shifting the 
cells to 37°C, P1-T1 looping signals decreased by about 5-fold for both 
MET16 and INO1 in the pap1-1 strain (Figure II.3., B and F, lane 2; and panels D and 
H, gray bars). No such diminution in looping signal was detected in the isogenic wild 
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type cells following the temperature shift to 37°C (Figure II.3., B and F, lane 2). When 
the CCC experiment was repeated in hrp1-5 mutant, no decrease in looping signal was 
observed either for MET16 and INO1 following temperature shift to 37°C (Figure II.3., B 
and F, lane 2; and panels C and G, gray bars). Thus, of the two factors investigated 
here, we found only Pap1 essential for gene looping. Although we did not observe any 
decrease in looping signal of genes in hrp1-5 strain at elevated temperature, we cannot 
make a conclusion regarding the role of Hrp1 in loop formation. To confirm the role of 
Hrp1 in gene looping, we need to check other temperature-sensitive mutant alleles of 
Hrp1.   
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II.3.3. Hrp1 and poly(A) polymerase occupy the distal ends of a gene in looped 
configuration 
Next, we wanted to see whether Hrp1 and Pap1 are present in the vicinity of the 
promoter regions of MET16 and INO1, as is the case with other CFI subunits. ChIP 
analysis was therefore performed to determine the presence of these two factors on 
different regions of MET16 and INO1 during the repressed and activated transcriptional 
states of genes. Our results show that both Hrp1 and Pap1 crosslinked to the terminator 
as well as the promoter regions of MET16 during activated transcription (Figure II.4., 
panels B and C, regions A and D). Identical results were obtained with INO1 (Figure 
II.4. d, panels E and F, regions A and D). Collectively, our previous and current 
chromatin immunoprecipitation studies suggest that in addition to their authentic 
position at the 3' end of genes, all the CFI subunits are also localized to the promoter 
region. This suggests a direct or indirect role for these subunits in the gene loop 
formation. 
II.4. DISCUSSION 
The results presented here demonstrate that both Hrp1 and Pap1 subunits of the 
previously reported holo-TFIIB complex are localized to the 5′ ends of genes only when 
they are in a looped conformation. Furthermore, we showed that the Pap1 plays a role 
in gene loop formation. Our results, however, were not conclusive regarding the role of 
Hrp1 in facilitating gene looping. We did not observe any decrease in the looping signal 
in the mutant strain for Hrp1. This does not completely rule out a role of Hrp1 in loop 
formation. It is quite possible that the point mutation in hrp1-5 does not interfere with its 
role in gene looping or it even enhanced this activity. Other conditional mutants for Hrp1 
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might be needed to demonstrate conclusively the role of Hrp1 in promoter-terminator 
interaction. Our results also emphasize the connection between gene looping and 
transcription. Whenever a gene is found in looped conformation, an increase in 
transcription of the gene is observed. Whether gene looping is the cause or the effect of 
enhanced transcription remains to be elucidated.  
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CHAPTER III 
A ROLE FOR CFIA 3` END PROCESSING COMPLEX IN PROMOTER ASSOCIATED 
TRANSCRIPTION 
This chapter has been published: 
Al Husini N, Kudla P, Ansari A (2013) A role for CF1A 3' end processing complex in 
promoter-associated transcription. PLoS Genet 9: e1003722. 
 
III.1. ABSTRACT 
             The Cleavage Factor 1A (CFIA) complex, which is required for the termination 
of transcription in budding yeast, occupies the 3′ end of transcriptionally active genes. 
We recently demonstrated that CFIA subunits also crosslink to the 5′ end of genes 
during transcription. The presence of CFIA complex at the promoter suggested its 
possible involvement in the initiation/reinitiation of transcription. To check this possibility, 
we performed transcription run-on assay, RNAPII-density ChIP and strand-specific RT-
PCR analysis in a mutant of CFIA subunit Clp1. As expected, RNAPII read through the 
termination signal in the temperature-sensitive mutant of clp1 at elevated temperature. 
The transcription readthrough phenotype was accompanied by a decrease in the 
density of RNAPII in the vicinity of the promoter region. With the exception of TFIIB and 
TFIIF, the recruitment of the general transcription factors onto the promoter, however, 
remained unaffected in the clp1 mutant. These results suggest that the CFIA complex 
affects the recruitment of RNAPII onto the promoter for reinitiation of transcription. 
Simultaneously, an increase in synthesis of promoter-initiated divergent antisense 
transcript was observed in the clp1 mutant, thereby implicating CFIA complex in 
providing directionality to the promoter-bound polymerase. Chromosome Conformation 
Capture (CCC) analysis revealed a physical interaction of the promoter and terminator 
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regions of a gene in the presence of a functional CFIA complex. Gene looping was 
completely abolished in the clp1 mutant. On the basis of these results, we propose that 
the CFIA-dependent recruitment of RNAPII onto the promoter for reinitiation and the 
regulation of directionality of promoter-associated transcription are accomplished 
through gene looping.  
III.2. INTRODUCTION 
The process of transcription can be divided into three principal steps; initiation, 
elongation and termination [33]. The accomplishment of each of these steps during the 
RNAPII-mediated transcription cycle requires a number of accessory factors. The 
initiation of transcription requires gene specific transcription factors as well as general 
transcription factors (GTFs): TFIID, TFIIB, TFIIA, TFIIF, TFIIE, TFIIH and Mediator 
complex, that assemble on the promoter to form the preinitiation complex 
[19,20,196,197]. The termination of transcription, which is intimately linked to the 
cleavage and polyadenylation of precursor mRNA, exhibits a similar requirement for a 
group of termination factors organized into two macromolecular complexes called 
Cleavage-Polyadenylation-Factor (CPF) complex and Cleavage Factor-1 (CFI) complex 
in yeast [54,61,62,75,198]. The initiation and termination factors have been remarkably 
conserved during evolution. The generally accepted view is that the initiation factors 
operate exclusively at the 5′ end of a gene and are committed to starting the 
transcription cycle, while termination factors have a dedicated role in ending the 
transcription cycle at the 3′ end of a gene. A number of recently published reports, 
however, challenge this dogma. It is evident that at least some initiation factors are also 
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necessary for termination, and the termination factors likewise may have a role in the 
initiation or reinitiation step of the transcription cycle [75,199-202].  
An increasing amount of biochemical, genetic and functional evidence suggests 
the existence of a network of complex interactions between initiation and termination 
factors. The general transcription factor TFIIB, for example, exhibits multiple genetic 
and physical interactions with the factors operating at the 3′ end of genes 
[93,103,120,203].  These studies suggested a plausible role for TFIIB in the termination 
process. Accordingly, it was recently demonstrated that TFIIB is indeed actively 
engaged in termination of transcription in mammals and flies [149,203]. Yeast Mediator 
subunit Srb5, which has a well-established function in the initiation of transcription, 
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likewise, crosslinks to the 3′ end of genes and participates in the termination process 
[204]. TFIID is another promoter-bound protein that contacts the factors operating at the 
3′ end of genes. Biochemical analysis of mammalian TFIID has revealed its reciprocal 
interaction with the CPSF 3′ end processing complex [130]. The TFIID-CPSF interaction 
is evolutionarily conserved. A recent proteomic analysis of yeast TFIID complex 
identified multiple interactions of TFIID subunit TAF150 with the components of the CPF 
3′ end processing complex, which is the yeast homologue of CPSF complex 
[105,119,124].  
Like initiation factors, an array of termination factors also crosstalk with the 5′ end 
of genes. The foremost among them is Ssu72, which was discovered as a protein of 
unknown function that genetically interacts with TFIIB [103]. Later on, yeast proteomic 
analysis identified Ssu72 as a component of the CPF 3′ end processing complex 
[115,205,206]. Ssu72 crosslinks to the 5′ end of genes, and interacts with several 
promoter-bound factors [104,107,110,116,119,132,136,207]. Pta1, which is a subunit of 
CPF complex, and Rat1 are other terminator-bound factors that physically interact with 
the 5′ end of genes and the associated initiation factors [132,133]. In addition to CPF 
complex, both 3' end processing and termination of transcription also require CFI 
complex. At least three subunits of this complex (Rna14, Rna15 and Pcf11) associate 
with both ends of a transcriptionally engaged gene [93,135]. CFIA subunits exhibit 
genetic and physical interaction with several promoter-bound factors that include both 
the general transcription factors and gene specific factors 
[74,93,104,108,111,114,120,126]. Furthermore, CFIA subunits are also required for 
juxtaposition of the promoter and terminator regions to form a looped gene structure 
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[93]. The well-orchestrated interaction of the distal ends of a gene strongly suggests 
that the termination and initiation steps of transcription may operate in a cooperative 
manner. 
The presence of termination factors on the promoter region could influence the 
events taking place at the 5′ end of genes. One possible role of the termination factors 
at the 5′ end could be to regulate initiation or reinitiation of transcription. It was recently 
demonstrated that proper termination of transcription is required for efficient execution 
of the transcription cycle in mammalian cells [164]. In that study, a termination defect 
adversely affected the recruitment of the general transcription factors onto the promoter 
of the same gene leading to a decrease in initiation of transcription. In a related study, a 
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decrease in the density of RNAPII at the promoter region was observed in the 
termination-defective Ssu72-C15S mutant [208]. One possible interpretation of these 
results is that proper termination is important for the recruitment of polymerase at the 
promoter for reinitiation. It is conceivable that the physical proximity of the promoter and 
terminator regions, which results in a looped gene conformation, facilitates a direct 
transfer of the released polymerase from the 3′ end to the juxtaposed promoter [132]. 
This would help bypass the rate-limiting step of recruitment of polymerase on the 
promoter, leading to enhanced transcription of the gene. A transfer of polymerase 
molecules from the terminator to the promoter has, indeed, been shown for RNAPIII-
transcribed genes [151]. We propose that a similar termination-reinitiation coupling is 
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taking place during RNAPII-mediated transcription as well. Another possible function of 
termination factors at the 5' end of genes could be in providing directionality to the 
promoter-bound RNAPII to transcribe the sense strand. Genome wide analysis of 
human and yeast systems revealed the unexpected finding that RNAPII tends to 
transcribe both in the sense as well as anti-sense direction from the promoter region 
[2,3,70,168]. The promoter initiated anti-sense transcription, however, is aborted, 
thereby favoring productive elongation of the sense transcript. What confers 
directionality to the promoter-bound polymerase remains unclear. A recent study carried 
out in budding yeast demonstrated that the termination factors inhibit transcription of the 
promoter-initiated anti-sense transcripts, thereby providing directionality to the 
promoter-bound polymerase [7].  
Here we demonstrate the role of CFIA complex in the promoter-associated 
transcription in budding yeast. In a mutant of Clp1 subunit of the CFIA complex, 
recruitment of the whole CFIA complex at the 3′ end of genes was compromised, 
leading to a termination defect. The termination defect coincided with a decrease in the 
recruitment of RNAPII on the promoter indicating a possible initiation defect. Since there 
was no significant decrease in the recruitment of the general transcription factors onto 
the 5′ end of a gene in the clp1 mutant, these results strongly suggest a novel role for 
the CFIA complex in reinitiation of transcription. We further found a role for CFIA 
complex in the inhibition of promoter-initiated anti-sense transcription. Thus, CFIA 
complex may have an additional function in providing directionality to bivalent yeast 
promoters. The CFIA-dependent promoter-based events coincide with the gene 
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assuming a looped conformation, thereby suggesting a possible role of gene looping in 
reinitiation of transcription in the sense direction.  
III.3. RESULTS 
            CFIA is a hexameric complex comprised of two subunits each of Rna14 and 
Rna15, and one subunit each of Pcf11 and Clp1 [77]. The Rna14, Rna15 and Pcf11 
subunits have been studied extensively due to the availability of conditional mutant 
alleles. In contrast, little is known about the physiological role of Clp1. Recent studies, 
however, have implicated Clp1 both in the 3′ end processing of precursor mRNA and in 
the termination of transcription [89,91,92]. Structural analysis using mutants revealed 
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that Clp1 makes a direct physical contact with the Pcf11 subunit of CFIA complex as 
well as with the Ssu72 and Ysh1 subunits of CPF complex [77,89,91].   
III.3.1. Clp1 is required for the recruitment of a termination-competent CFIA 
complex on transcriptionally active genes 
To further analyze the role of Clp1 in transcription, we used a temperature-
sensitive mutant of the factor called clp1-769-5 [209]. Western blot analysis revealed 
that the Clp1 protein almost completely disappeared from the mutant cells following the 
temperature shift to 37oC, but there was only a marginal change in the signal for other 
CFIA subunits at the elevated temperature (Figure III.1). We examined the transcription 
of INO1 and CHA1 in the mutant clp1 strain in cells grown at the permissive (25oC) and 
non-permissive (37oC) temperatures. The selection of INO1 and CHA1 was simply 
because their transcriptional regulation is well understood and can be induced under 
laboratory conditions.  Furthermore, CHA1 is relatively isolated in the yeast genome and 
therefore is a good candidate to study upstream and downstream transcription by 
transcription run-on (TRO) assay. RT-PCR was carried out using primers A and B as 
shown in Figure III.2, A and D in the mutant and wild type strains at 25oC and 37oC. RT-
PCR analysis revealed that the transcript level of both INO1 and CHA1 decreased by 
about 4-8 fold upon shifting the mutant cells to 37oC (Figure III.2, B and E, lane 4; 
Figure III.2, C and F). No such decrease in transcript level was observed upon shifting 
the wild type cells to elevated temperature (Figure III.2, B and E, lane 4; Figure III.2, C 
and F). Thus, Clp1 is essential for optimal transcription of both INO1 and CHA1 in 
yeast. Since there was no appreciable decrease in the amount of CFIA subunits Rna14, 
Rna15 and Pcf11 in the mutant cells at the elevated temperature (Figure III.2), we next 
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checked if CFIA complex is recruited at the 3′ end of genes in the mutant cells. ChIP 
analysis revealed that the recruitment of Rna14, Pcf11 and Rna15 at the 3′ end of INO1 
and CHA1 exhibited a decline following the temperature shift to 37oC (Figure III.3, B and 
D, lanes 4, 12 and 20). No such decrease in the recruitment of CFIA subunits was 
observed in the wild type cells at elevated temperature (Figure III.4, B and D, lanes 4, 
12 and 20). The overall conclusion of these results is that the normal expression of 
INO1 and CHA1 is dependent on Clp1, and that the recruitment of a functional CFIA 
complex at the 3′ end of these two genes occurs in a Clp1-dependent manner.  
To understand the role of Clp1 in the transcription cycle, we performed 
transcription run-on (TRO) analysis of CHA1 in the wild type and temperature-sensitive 
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clp1-769-5 strains during different transcriptional states of the gene. The transcription of 
CHA1 is regulated by the nitrogen source in the growth medium. The gene is 
maintained in a transcriptionally repressed state in a medium containing ammonium 
sulfate as the nitrogen source, and is stimulated upon shifting cells to a medium 
containing serine and threonine [210]. The position of transcriptionally active RNAPII 
was monitored at the positions A to I as shown in Figure III.5, A. The TRO analysis 
found transcriptionally active RNAPII being almost uniformly distributed between the 
promoter and the terminator regions of CHA1 in the wild type strain during induced 
transcription (Figure III.5, B, lanes 3-7 and 13-17; Figure III.5, D). In the clp1-769-5 
mutant, however, the polymerase read through the termination signal into the 
downstream region at elevated temperature (Figure III.5, C, lanes 38 and 39; Figure 
III.5, E). No such transcription readthrough was observed in the mutant strain at the 
permissive temperature   (Figure III.5.C, lanes 28 and 29; Figure III.5.E) or in the wild 
type cells at 37oC (Figure III.5, B, lanes 18 and 19; Figure III.5, D). Strand-specific RT-
PCR analysis corroborated the presence of sense transcripts downstream of the 
termination signal of CHA1 in the clp1 mutant at elevated temperature (Figure III.6, B, 
region Z). No such readthrough transcripts were observed in the isogenic wild type 
strain under identical conditions (Figure III.6, C, region Z). Strand-specific RT-PCR 
analysis was carried out using primers shown in Figure III.6, A and described in the 
figure legend. A logical conclusion of these results is that Clp1 is a termination factor in 
budding yeast. 
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III.3.2. A functional CFIA complex is required for reinitiation of transcription 
Recently, we demonstrated crosslinking of Rna14, Rna15 and Pcf11 subunits of CFIA 
complex to the distal ends of genes in a transcription-dependent manner [93]. Here we 
show that the Clp1 subunit also localizes to both the 5′ and 3′ ends of transcriptionally 
active INO1 and CHA1(Figure III.7, B and E, lanes 1 and 4; Figure III.7, C and F). The 
CFIA complex, being a cleavage-polyadenylation factor, is expected to bind to the 3′ 
end of genes. It was, however, intriguing to find the entire CFIA complex occupying the 
5′ end of genes as well. A clue regarding the role of the CFIA complex at the 5′ end of 
genes came when we observed that the transcription readthrough phenotype of the 
mutant strain at the elevated temperature was accompanied by a decrease in the TRO 
signal in the promoter-proximal coding region (Figure III.5., C, lane 33). This result 
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strongly suggested a role for Clp1 in the initiation/reinitiation of transcription. To 
determine if the observed decrease in TRO signal near the 5′ end of CHA1 in the 
mutant was due to a failure to recruit RNAPII onto the promoter or due to a post-
recruitment defect, we performed RNAPII density ChIP during the transcriptionally 
activated state of INO1 and CHA1 in clp1-769-5 strain at permissive and non-
permissive temperatures. RNAPII ChIP was performed using primer pairs A, B, C, D, 
E, and F as indicated in Figure III.8, A and D. Our results show that there was indeed a 
decrease in the density of RNAPII at the promoter region of both INO1 and CHA1 at 
elevated temperature (Figure III.8, B, lanes 1, 2 and Figure III.8, C, regions A, B; 
Figure III.8, E, lane 1 and Figure III.8, F, region A). There was no such decrease in the 
polymerase density at the promoter region of genes in the wild type cells at 37oC  
(Figure III.9, B and E lanes 1 and 2; Figure III.9, C and F). The RNAPII-ChIP 
experiment revealed a nearly 2-fold decrease in the polymerase signal at the 5ʹ end of 
CHA1 in the mutant at 37oC (Figure III.8, F, region A). In contrast, the TRO assay 
showed an at least 5-fold decrease in the polymerase signal near the promoter region 
of CHA1 under identical conditions (Figure III.5.E, region C). This discrepancy could be 
attributed to the presence of transcriptionally inactive paused polymerase near the 5ʹ 
end of CHA1 that can be detected by ChIP assay, but not by the TRO assay. The 
overall conclusion of both the TRO and RNAPII-density ChIP results is that there is 
clearly a decrease in the amount of polymerase at the 5ʹ end of a gene in the clp1 
mutant at elevated temperature. A plausible interpretation of these results is that a 
functional CFIA complex facilitates the recruitment of RNAPII onto the promoter during 
transcription.  Next we asked if CFIA-dependent recruitment of RNAPII on the promoter 
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occurs during the initiation or reinitiation of transcription. The recruitment of TFIID, 
TFIIB, TFIIA, TFIIF, RNAPII, TFIIE and TFIIH occurs in this order in a sequencial 
manner during preinitiation complex (PIC) assembly [211,212]. The recruitment of 
RNAPII occurs subsequent to the formation of a TFIID-TFIIB-TFIIA complex on the 
promoter. This is followed by the binding of TFIIE and TFIIH to form the PIC. Following 
initiation of transcription, RNAPII along with TFIIF is released from the complex for 
elongation [34]. Simultaneously, TFIIB is also released from the complex, while the rest 
of the general transcription factors are left behind on the promoter forming a ‘scaffold’ 
that is used as a loading dock for the re-entry of RNAPII for reinitiation of transcription 
during subsequent transcription cycles. The composition of protein factors on the 
promoter, therefore, can distinguish an ‘initiation complex’ from the ‘reinitiation scaffold’ 
54 
 
 
 
[202]. The initiation complex will contain all general transcription factors along with 
RNAPII, while the reinitiation scaffold will have general transcription factors with the 
exception of TFIIB and TFIIF and no RNAPII. Thus, to determine if CFIA-dependent 
recruitment of RNAPII was occurring during the initiation or reinitiation of transcription, 
we examined the promoter occupancy of INO1 and CHA1 for TFIID, TFIIB, TFIIF, 
TFIIE and TFIIH in clp1-769-5 strain at the permissive and non-permissive 
temperatures by ChIP assay using primer pairs indicated in Figures III.10, A and C. 
Our results demonstrate that TFIID, TFIIB, TFIIF, TFIIE and TFIIH occupied the 
promoter region of both genes in the mutant at 25oC as well as 37oC (Figure III.10, B 
and D, region A black bar). Similar results were observed in the isogenic wild type 
strain (Figure III.13). TFIIB also occupied the terminator region of both genes at 25oC 
(Figure III, 10 B and D, region D grey bar for TFIIB-ChIP panel). The presence of TFIIB 
at the 3ʹ end of genes is linked to CFIA-dependent gene looping [18]. A decrease in 
TFIIB signal near the 3ʹ end of both INO1 and CHA1 was observed in the clp1 mutant 
at 37oC (Figure III.10, B and D, region D grey bar for TFIIB-ChIP panel). This is in 
accord with the observed decrease in the TFIIB occupancy of the terminator region of 
transcriptionally active genes in the mutants of CFIA subunits [18]. A 25% decrease in 
the crosslinking of TFIIB and TFIIF to the promoter region of both INO1 and CHA1 was 
also observed in the mutant following the temperature shift to 37oC (Figure III.10, B and 
D, region A 
 grey bar). This is in agreement with the reported release of TFIIB and TFIIF from the 
promoter following initiation of transcription [34]. There was no appreciable change in 
the promoter occupancy of the rest of the general transcription factors following a shift 
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to elevated temperature, despite a decrease in the promoter-bound RNAPII signal. 
These results suggest that it is the reinitiation of transcription that is adversely affected 
in the clp1-769-5 cells at elevated temperature. The overall conclusion of these results 
is that a functional CFIA complex is required for the recruitment of polymerase to the 
promoter for reinitiation of transcription. The possibility of CFIA complex being required 
for the recruitment of TFIIB and TFIIF for reinitiation cannot be ruled out.  
III.3.3. CFIA complex limits divergent anti-sense transcription at the promoter 
During the transcription cycle, RNAPII in the promoter-bound initiation complex 
transcribes in the sense direction, producing mRNA. Genome wide analysis of 
transcribing polymerases has identified RNAPII molecules in the region just upstream of 
the transcription start site in most eukaryotic genes [2,3,70,168]. These upstream 
polymerases are involved in divergent anti-sense transcription, producing non-coding 
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RNA (ncRNA). These promoter-initiated, anti-sense ncRNAs are capped, non-
adenylated, heterogeneous in size and often belong to a class of RNA called CUTs  
(cryptic unstable transcripts) that are rapidly degraded by the RNA surveillance 
mechanism of the cell [171,213].  Having already implicated CFIA complex in the sense-
transcription of mRNA, we next asked if CFIA complex has a role in the regulation of 
divergent, anti-sense transcription of ncRNA. To address the issue, we performed 
strand-specific RT-PCR for CHA1 in wild type and clp1-769-5 mutant as described in 
[169]. In wild type cells, we could not detect promoter-initiated anti-sense transcripts 
under any condition (Figure III.3, C, region W). In the clp1-769-5 mutant also, no 
appreciable divergent anti-sense RNA could be detected at 25oC (Figure III.6., B, region 
W, black bar). At the elevated temperature, however, a 5-fold increase in the signal for 
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promoter-associated anti-sense transcripts was observed in the mutant strain (Figure 
III.6, B, region W, grey bar). These results were corroborated by TRO assay, which 
detected the presence of transcriptionally engaged polymerase in the region upstream 
of CHA1 in the mutant strain at 37oC (Figure III.5, C, lane 31; Figure III.5, E region A).  
The increase in the level of divergent anti-sense transcripts initiating from the 5ʹ end of 
the gene in the mutant could be attributed either to the stabilization of the transcripts or 
58 
 
 
 
to the synthesis of promoter-initiated anti-sense transcripts in the mutant. Since the 
TRO assay detected the presence of transcriptionally active RNAPII just upstream of 
the promoter of CHA1 in the clp1 mutant at elevated temperature, it is reasonable to 
conclude that the observed anti-sense transcripts were not the consequence of 
stabilization of RNA, but the result of divergent anti-sense transcription initiating from 
the 5ʹ end of the gene. These results raise the possibility of a role for the CFIA complex 
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in limiting the transcription of promoter-associated anti-sense ncRNA, thereby favoring 
transcription of mRNA in the sense direction. We therefore propose that the CFIA 
complex may have an additional role in providing directionality to otherwise bidirectional 
yeast promoters. Our results are in agreement with a recent report that showed an 
increase in promoter-initiated divergent anti-sense transcription in termination-defective 
mutants [7].   
Thus, in the absence of a functional CFIA complex in the clp1-769-5 mutant, the 
promoter-associated downstream transcription of mRNA in the sense direction as well 
as the divergent upstream transcription of anti-sense RNA, exhibited an aberrant 
pattern.  
III.3.4. A role for CFIA-dependent gene looping in promoter-associated 
transcription 
A logical interpretation of the results described above is that the CFIA complex is 
not merely contacting the 5′ end of transcriptionally active genes, but is also influencing 
early events in the transcription cycle. Next we asked how the CFIA complex is 
recruited to the 5′ end of a gene. The binding of CFIA complex to the 5′ end could be 
independent of its recruitment at the 3′ end of a gene. Alternatively, gene looping, which 
is the transcription-dependent interaction of the promoter and the terminator regions of 
a gene, may facilitate positioning of the terminator-bound CFIA complex at the 5′ end of 
a gene [132]. We have earlier demonstrated the role of CFIA subunits Rna14, Rna15 
and Pcf11 in gene looping [18]. To corroborate the role of CFIA complex in gene loop 
formation, we performed 3C analysis of INO1 and CHA1 in the clp1-769-5 mutant at the 
permissive and non-permissive temperatures. Gene looping was monitored by the P1-
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T1 primer pair shown in Figure III, 12, A and D, by the method described in [214]. A 
distinct P1-T1 PCR signal was obtained for both INO1 and CHA1 when the mutant cells 
were grown at 25oC (Figure III.12., B and E, lane 1; Figure III.12., C and F, black bar). 
The P1-T1 looping signal decreased by about 4-6 fold following transfer of cells to 37oC 
(Figure III.12., B and E, lane 2; Figure III.12., C and F, grey bar). These results 
confirmed that a functional CFIA complex is indispensable for gene loop formation in 
budding yeast.  
III.4. DISCUSSION 
The CFIA complex, which is known to localize and operate at the 3′ end of 
RNAPII-transcribed genes in yeast, also contacts the 5′ end of genes. The promoter 
occupancy of the CFIA complex coincides with the gene assuming a looped 
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conformation. We recently purified a holo-TFIIB complex that contained all the CFI 
subunits and the general transcription factor TFIIB [93]. We showed that the holo-TFIIB 
complex mediates gene loop formation by simultaneously contacting the distal ends of a 
gene. Accordingly, gene looping was not observed in mutants of the Rna14, Rna15 and 
Pcf11 subunits of CFI complex. Here we show that gene looping is abolished in the clp1 
mutant as well. Whether the presence of CFIA at the 5′ end is the cause or the effect of 
gene looping is still unclear, but it is quite evident that the CFIA subunits at the 5′ end of 
a gene affect early events during the transcription cycle. The CFIA-dependent gene 
loop juxtaposes the terminator region of a gene with its cognate promoter. This 
arrangement may facilitate binding of the RNAPII released from the terminator at the 
end of a transcription cycle to the promoter for starting the next round of transcription. 
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Accordingly, we observed a 2-fold decrease in the RNAPII density at the promoter in the 
absence of a functional CFIA complex. Since the promoter occupancy of the general 
transcription factors, with the exception of TFIIB and TFIIF, remained unaltered in the 
clp1 mutant, we propose that the CFIA complex, by virtue of its role in gene looping, 
affects reinitiation rather than initiation of transcription. The possibility of CFIA subunits 
playing a role in the initiation, however, still cannot be ruled out. A similar study carried 
out in a mammalian system found termination factors affecting initiation rather than 
reinitiation of transcription [164]. The mechanism of termination-dependent initiation, 
however, was not clear in that study. Here we propose that the CFIA-dependent gene 
looping may account for the termination-reinitiation link.  
Since a majority of eukaryotic promoters are intrinsically bidirectional, there 
should be some mechanism in the cell to favor transcription of mRNA in the sense 
direction, over the anti-sense transcription of ncRNA [2]. We found that the CFIA 
complex, while facilitating reinitiation in the sense direction, has an additional function in 
restricting transcription of the promoter-associated anti-sense RNA. The divergent, anti-
sense transcription of ncRNA is widely believed to be terminated by the Nrd1-
dependent pathway in yeast [4]. The CFIA complex, in general, is associated with the 
termination of mRNA synthesis by the poly(A)-dependent pathway [54,198]. Our results 
suggest that CFIA complex may be involved in the termination of anti-sense ncRNA 
synthesis as well. These results are in agreement with a recent report that 
demonstrated crosslinking of mammalian termination factors Xrn2 and TTF2 to the 5′ 
end of genes and their involvement in limiting promoter-initiated anti-sense transcription 
[177]. The regulation of transcriptional directionality by Ssu72, which is a subunit of the 
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CPF 3' end processing complex in yeast, further corroborates our results [7]. The 
limiting of promoter-initiated anti-sense transcription may direct the polymerase to move 
in the sense direction, thereby producing mRNA. Thus, CFIA complex may be involved 
in providing directionality to bivalent promoters.  
Based on these results we propose a model of transcription by RNAPII (Figure 
III.13). The transcription-dependent promoter-terminator interaction places CFIA 
complex in the vicinity of the promoter. The promoter-bound CFIA affects transcription 
at two levels. First, CFIA-dependent termination releases RNAPII molecules from the 3′ 
end of gene near the promoter, thereby facilitating the recruitment of RNAPII to the 
promoter for reinitiation. Secondly, it provides directionality to the bidirectional promoter, 
thereby promoting the synthesis of mRNA over anti-sense ncRNA. Whether the CFIA 
complex limits promoter-initiated anti-sense transcripts by virtue of its termination 
activity needs further investigation. The net result is an upregulation of mRNA synthesis 
in the presence of a functional CFIA complex. Although a role for gene looping in 
facilitating transfer of polymerase from the terminator to the promoter for reinitiation has 
previously been hypothesized, this is the first instance where gene looping has actually 
been shown to help reinitiation of transcription. 
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CHAPTER IV 
GENOMEWIDE ANALYSIS OF CLP1 FUNCTION IN TRANSCRIPTION IN BUDDING  
YEAST 
IV.1. ABSTRACT 
In budding yeast, both the 3' end processing of mRNA and the termination of 
transcription by RNAPII requires the function of the CFIA complex. The CFIA complex 
consists of four subunits, Rna14, Rna15, Pcf11, and Clp1. Unlike the first three 
subunits, the precise role of Clp1 subunit has not been thoroughly investigated. We 
have earlier demonstrated a role for this factor in transcriptional termination of the CHA1 
gene and found a decrease in the recruitment of the CFIA complex to the 3' end of this 
gene when its function is compromised. We further showed a function for this factor in 
promoter-associated transcription, wherein the function of Clp1 is required for the 
prevention and/or termination of the upstream antisense transcription initiated from the 
promoter of CHA1. To assess the generality of the observed functions of Clp1 in 
transcription, we tested the effect of Clp1 on transcription by RNAPII on a genomewide 
scale using the Genome Run-On (GRO-Seq) approach. Our results show a decrease in 
overall transcription when the function of this protein is compromised. Our results 
demonstrate a genomewide role for Clp1 in the termination of transcription, and further 
suggest that Clp1 is required for the RNAPII pausing that precedes the termination of 
transcription. Interestingly, we observed a dramatic increase in 3' initiated antisense 
transcription in the absence of a functional Clp1 protein. Additionally, the density of 
transcriptionally active polymerase at the 5' end of genes also exhibited a significant 
decrease in the Clp1 mutant at the elevated temperature. These results affirm the role 
of Clp1 in promoter-associated transcription on a genomewide scale.  
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IV.2. INTRODUCTION 
The CFIA 3ʹ end processing complex of budding yeast is composed of four 
subunits: Rna14, Rna15, Pcf11 and Clp1 [54,72]. Besides cleavage and 
polyadenylation, the complex has also been implicated in the termination of transcription 
[48]. The termination function of the CFIA complex was demonstrated using a nuclear 
run-on assay that revealed the readthrough of RNAPII beyond the poly(A) site in the 
mutants of all four CFIA subunits [48,215]. The transcription readthrough phenotype, 
however, has been demonstrated for just a few selected yeast genes. ChIP analysis 
identified all four subunits of the CFIA complex localized at the 3ʹ end of selected genes 
in accordance with their role in 3ʹ end processing and termination of transcription 
[93,215]. Genomewide analysis found Pcf11 crosslinked to the 3ʹ end of a majority of 
transcriptionally active yeast genes [216]. This observation suggests that the CFIA 
complex may play a general role in the termination of transcription in budding yeast. 
More direct evidence in support of a role for the CFIA complex in the termination of 
transcription on a genomewide scale, however, is needed to firmly establish it as a 
general termination factor.  
A vast majority of RNAPII-transcribed genes in yeast and higher eukaryotes 
exhibit anti-sense transcription initiating from the 5' as well as the 3' end of genes 
(Figure IV.1) [217,218]. In yeast, the 5' end initiated anti-sense transcripts are rapidly 
degraded by the RNA surveillance machinery of the cell and are therefore referred to as 
‘cryptic unstable transcripts’ (CUTs) [7]. In contrast, the 3' end initiated anti-sense 
transcripts are stable and belong to the category of ‘stable unannotated transcripts’ 
(SUTs) [217].  At least 50% of SUTs in budding yeast are 3' end initiated anti-sense 
66 
 
 
 
transcripts. A number of genes in yeast and mammalian cells exhibit 3' end initiated 
antisense transcription under repressed conditions. The GAL10 gene of budding yeast, 
for example, exhibits robust sense transcription in the presence of galactose [219,220]. 
Upon shifting of the cells to glucose containing medium, however, sense transcription is 
almost completely inhibited, and the 3' end initiated anti-sense transcription 
predominates. In mammalian cells, the assembly of the PIC at the promoter region of 
genes is adversely affected in the termination defective mutant cell lines [164]. Instead, 
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the assembly of the PIC was observed at the 3' end of genes. Such PICs formed at the 
3' end of genes are capable of driving 3' end initiated anti-sense transcription. The 
initiation of sense transcription under these conditions is severely compromised. It has 
been proposed that when the 3' end initiated anti-sense transcript reaches the promoter 
end of the gene it may adversely affect initiation/reinitiation either through transcriptional 
interference or through histone modification [221-223]. Whether 3' end initiated anti-
sense transcription is a general feature of termination defective mutants, however, is not 
clear. It is possible that proper termination is necessary to keep 3' end initiated anti-
sense transcription under control. When the termination is compromised, anti-sense 
transcription from the 3' end is activated, which in turn adversely affects the initiation of 
transcription from the promoter.   
Since the CFIA complex is involved in the cleavage-polyadenylation of mRNA 
and termination of transcription, it is expected to be present near the 3ʹ end of genes. It 
was, however, intriguing to find all four subunits of the CFIA complex occupying the 5ʹ 
end of genes as well [93]. Furthermore, the Ssu72 subunit of the CPF complex, which is 
also linked to 3ʹ end processing and termination of transcription in budding yeast, has 
been localized to the promoter end of genes [132,224]. The presence of termination 
factors towards the 5ʹ end of genes is an evolutionarily conserved feature as a number 
of 3ʹ end processing/termination factors of higher eukaryotes also have been found 
crosslinked to the distal ends of genes [184]. The promoter occupancy of termination 
factors remained an enigma until recently when it was demonstrated that these factors 
provide directionality to transcription by limiting divergent antisense transcription 
initiating from the promoter region [7,184,215]. The majority of promoters of RNAPII-
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transcribed genes in yeast and mammals are bidirectional. The transcription from these 
promoters initiates in both the downstream sense direction as well as the upstream 
antisense direction. The downstream sense transcription of the coding region produces 
mRNA, while the upstream antisense transcription produces a ncRNA (called CUT in 
yeast) that is rapidly degraded. Transcription in the upstream antisense direction is 
terminated within a few hundred bases from the transcription start site by the 
termination factors residing in the promoter region, while productive transcription in the 
sense direction is allowed to proceed until the polymerase reaches the 3ʹ end of the 
gene. Thus, promoter linked termination factors provide directionality to the inherently 
bidirectional eukaryotic promoters by limiting upstream antisense transcription [7,184]. A 
recent report suggested that the CFIA complex may be involved in providing 
69 
 
 
 
directionality to bivalent yeast promoters [215]. Whether the CFIA complex has a 
general role in conferring promoter directionality during RNAPII-mediated transcription 
in budding yeast, however, needs further investigation.  
Using a temperature-sensitive mutant of Clp1, we recently demonstrated the role 
of the CFIA complex in termination of transcription as well as in the promoter 
directionality of the CHA1 gene in budding yeast [215]. Here we extend this study to 
show that the CFIA complex has a general role in the termination of transcription in 
budding yeast. Employing the GRO-Seq approach, we further showed that the CFIA 
complex suppresses anti-sense transcription initiating from the 3' end of genes. It is also 
involved in providing directionality to the promoter of a subset of yeast genes. This 
study will serve as a paradigm to probe the role of other 3ʹ end processing factors of 
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yeast in the termination of transcription as well as in promoter directionality on a 
genomewide scale.   
IV.3. RESULTS AND DISCUSSION 
Of the three steps of the RNAPII transcription cycle (initiation, elongation and 
termination), initiation is the most well understood step. The general initiation factors are 
well characterized, and it is possible to perform initiation of transcription from a defined 
promoter using highly purified factors under in vitro conditions. In contrast, termination is 
the least understood step of the transcription cycle. The accessory factors required for 
termination are not thoroughly characterized. Consequently, termination of transcription 
under in vitro conditions using purified yeast factors has not been achieved so far. Like 
initiation, termination also requires cis acting DNA elements. The most common DNA 
element required for termination is the poly(A) site, which in higher eukaryotes is 
characterized by a conserved hexameric sequence, AAUAAA. Besides the poly(A) site, 
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other cis acting elements are required for efficient termination, both in yeast and in 
higher eukaryotes. Following transcription of the poly(A) site, RNAPII pauses (Figure 
I.3). A combination of biochemical and genetic approaches has identified two 
macromolecular complexes called CFI and CPF being essential for both 3ʹ end 
processing and termination of transcription [43,52,54]. Phosphorylation of RNAPII CTD 
plays a crucial role in the recruitment of the 3ʹ end processing/termination factors. The 
CFI complex is recruited to the termination site due to the interaction of Pcf11 subunit of 
the CFI complex with the serine-2 phosphorylated CTD [84]. The interaction of the 
Rna15 and Hrp1 subunits of the CFI complex stabilizes the association of the CFI 
complex with the elongating RNA. The Clp1 subunit of the CFI complex facilitates 
recruitment of the CPF complex to the site of termination [92]. This is followed by 
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cleavage and polyadenylation of the mRNA. The processed mRNA is released, and the 
Rat1 containing complex facilitates dissociation of polymerase from the template [133].  
It has been shown that a mutation in any subunit of the CFI complex and some subunits 
of the CPF complex adversely affects termination [48]. When termination is defective, 
RNAPII does not pause and dissociate from the template beyond the poly(A) site, but 
reads through the poly (A) termination signal. This transcription readthrough phenotype 
is characteristic of defective termination, and has been widely used to determine the 
involvement of a factor in the termination of transcription.  
IV.3.1. Clp1 is required for the termination of transcription on a genomewide scale 
A number of experimental approaches can be used to detect the termination 
defect on a genome-wide scale [225]. The most popular among them are the Northern 
blot, RNA-Seq, RNAPII-ChIP-Seq, NET-Seq, and GRO-Seq. All these approaches may 
give similar results, but there are subtle differences in the precise information they 
reveal. Traditionally, and before the recent revolution in sequencing methodologies, two 
approaches were widely used to assess the termination defects; RNAPII-ChIP and the 
nuclear run-on (NRO) assay. The first is based on crosslinking, followed by shearing of 
the crosslinked chromatin, and purifying the RNAPII-bound DNA using antibodies 
specific for polymerase subunits. RNAPII-ChIP-Seq is a large scale version of this 
protocol, in which the tedious job of detecting the signal for individual genes is replaced 
by subjecting the coimmunoprecipitated DNA fragments to high-throughput sequencing 
[226]. This method, although effective in determining the location of RNAPII molecules 
in the genome, cannot distinguish transcriptionally active polymerase from the inactive 
molecules. In addition, it does not provide any information regarding the strand being 
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transcribed by the bound polymerase. The second traditional approach used for 
assessing the termination defect is the NRO assay [48]. This assay measures the 
density of transcriptionally active polymerase over a specific region of the genome. 
Briefly, this assay is done under conditions that prevent new initiation events while 
allowing the engaged polymerase molecules to transcribe RNA in the presence of a 
radiolabeled nucleotide. The labeled nascent RNA is then allowed to hybridize to DNA 
probes on a nylon membrane. The probes are DNA fragments from the region under 
investigation. The intensity of the signal is detected using autoradiography. The 
genomewide version of this assay, called ‘Global Run-On-Seq (GRO-Seq), overcomes 
the limitations in the NRO assay in genome coverage and the strand specificity [70]. In 
GRO-Seq, the newly synthesized transcripts incorporate BrUTP, which allow for the 
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affinity purification of these nascent transcripts on an anti-BrUTP column. The resultant 
nascent RNAs are subjected to high throughput sequencing. The outcome of GRO-Seq 
is the snapshot of the position as well as the density of the actively engaged 
polymerase in a strand specific manner. Another possible way of detecting the 
termination defects is the Native Elongating Transcript Sequencing (NET-Seq) 
approach [227]. In this technique, polymerase-bound nascent transcripts are 
coimmunoprecipitated and subjected to deep sequencing. This method allows the 
measurement of engaged polymerase. The major drawback of this method, however, is 
its inability to determine if the engaged polymerase is transcriptionally engaged or it is 
simply a paused or backtracked polymerase. The fourth method for detecting 
transcription defects is RNA-Seq [228]. In this method the whole RNA pool isolated from 
the cell is subjected to deep sequencing. Although this method can assess strand 
specificity and can be a very good indicator of the transcriptional state of the cell, it may 
not be able to detect transcripts with short half lives. To assess the role of the CFIA 
subunit Clp1 in transcription on a genomewide scale, we used the GRO-Seq approach, 
as it gives a snapshot of the position of transcriptionally engaged polymerase in the 
nucleus in a strand-specific manner. Comparing the GRO-Seq maps of the 
temperature-sensitive mutant of Clp1and the isogenic wild type strain at the permissive 
(25oC) and non-permissive (37oC) temperatures of the mutant can reveal if Clp1 is a 
universal termination factor like the general transcription factors, or its role in 
termination is restricted to a subset of genes. Accordingly, we performed GRO-Seq 
analysis in the Clp1 mutant and the isogenic wild type strains in the cells grown at 25oC 
and 37oC. The experiment with the Clp1 mutant was performed in duplicate. The 
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correlation between the replicates ranged from 83%-95% (Table IV.2). The number of 
transcriptionally active genes was determined by using an experimentally determined 
threshold of 25 reads per kilobase. We found that ~5200 of the 6693 annotated ORFs 
(~78 %) in the Saccharomyces Genome Database (SGD) were expressed as tags 
above the background (Table IV.1).  
To investigate the role of Clp1 in the termination of transcription, we mapped 
GRO-Seq reads to the annotated 3' end of genes. For this analysis, we removed all 
those genes whose next neighboring gene from the 3' end was equal to or less than 700 
bp away. This was done because of the compact nature of the yeast genome, and often 
the terminator region of a gene overlaps with the promoter or terminator elements of the 
neighboring gene. We therefore restricted our analysis to 634 genes whose 3' end was 
at least 700 bp away from the neighboring ORF. We first compared the number of 
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genes transcribed in the Clp1 mutant at the permissive and non-permissive 
temperatures. Our results show that the number of genes transcribed in the mutant at 
25oC was reduced by about 25% upon shifting the cells to 37oC (Table IV.1). This is in 
agreement with the observed decrease in growth rate and transcription in the mutant at 
the non-permissive temperature (Figure IV.2). Next we compared the transcription 
readthrough phenotype in the mutant at 25oC and 37oC. We found that there was no 
decrease in the number of reads beyond the 3' end of genes upon shifting the cells to 
37oC (Figure IV.3). Furthermore, the number of reads beyond the 3' of the genes was 
more or less the same at the permissive and non-permissive temperature (Figure IV.3). 
Thus, the mutant was showing a readthrough phenotype even at the permissive 
temperature. It is not uncommon for temperature-sensitive mutants to exhibit the 
defective phenotype even at the permissive temperature. We therefore compared the 
readthrough phenotype in the mutant and the wild type strain at 37oC. The wild type 
strain exhibited a distinct peak towards the 3' end of genes (Figure IV.4). The peak was 
followed by a sharp drop off beyond the presumed polyadenylation signal. In contrast, 
there was neither a peak in the corresponding region at the 3' end, nor was there a 
decrease in the number of reads beyond the polyadenylation signal in the mutant at 
37oC (Figure IV.4). A logical interpretation of these data is that the polymerase reads 
through the termination signal in the mutant, but not in the isogenic wild type strain, at 
37oC.  
We draw two important conclusions from these results. First, Clp1 is a general 
termination factor. Of the 634 genes analyzed here, a majority of genes exhibit the 
readthrough phenotype in the Clp1 mutant at 37oC. No such readthrough was observed 
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in the wild type strain at 37oC. Second, Clp1 is required for the pausing of RNAPII near 
the 3' end of genes. It is generally believed that RNAPII pauses while transcribing the 
polyadenylation signal, and that this pausing is essential for the subsequent cleavage-
polyadenylation reaction that precedes termination [54]. Here we show pausing of the 
polymerase towards the 3' end of genes on a genomewide scale in the wild type cells. 
No such pausing was observed in the mutant at 37oC. On the basis of these results, we 
propose that Clp1 is one of the factors that contribute to the pausing of polymerase 
before the termination of transcription in budding yeast. Since there is no report of Clp1 
acting alone or being a part of any complex except for CFI, we extrapolate these results 
to propose that the CFI complex is an essential termination factor in budding yeast, and 
that it contributes to the pausing of the polymerase near the 3' end of genes in budding 
yeast.  
IV.3.2 Clp1 regulates anti-sense transcription 
Transcriptome analysis in yeast and higher eukaryotes has revealed that a vast 
majority of transcripts do not code for any protein [9]. These non-coding transcripts 
(ncRNAs) are the result of pervasive transcription. The anti-sense transcripts are a type 
of ncRNA that are produced from the anti-sense strand of annotated genes [217]. The 
anti-sense transcripts initiate from both the 5' end as well as the 3' end of genes (Figure 
IV.1). Those initiating from the 5' end are called pstream antisense RNA (uaRNA) [2]. A 
vast majority of RNAPII promoters in yeast as well as higher eukaryotes are 
bidirectional [2,3]. The transcription initiates from such promoters both in the sense as 
well as the anti-sense direction (Figure IV.1). The anti-sense transcripts are terminated 
when they are just a few hundred nucleotides long, while the sense transcription of the 
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coding region is allowed to proceed until the polymerase reaches the 3' end of the gene 
[168] [70,184]. Recent studies have revealed that the 3' end processing/termination 
machinery of the cell confers promoter directionality by terminating the transcription of 
uaRNA when it is just a few hundred nucleotides long [7,184,215]. The resultant uaRNA 
is extremely unstable, and is immediately degraded by the RNA surveillance machinery 
of the cell [168]. It has been demonstrated that gene looping plays a crucial role in the 
termination of uaRNA synthesis in budding yeast [7,215]. In the absence of gene 
looping, promoter directionality is compromised and longer uaRNA fragments are 
detected in the cell. We showed that Clp1 is essential for both the gene looping and the  
promoter directionality of the CHA1 gene in budding yeast [215]. To determine the 
generality of the role of Clp1 in the termination of uaRNA synthesis, and thus the 
maintenance of promoter directionality in budding yeast, we mapped GRO-Seq reads of 
the mutant and the wild type cells grown at 37oC, to the annotated 5' end of genes. For 
this analysis, we choose only those genes whose 5' end was at least 700 bp from the 
neighboring genes. We therefore restricted our analysis to 1247 genes. We were unable 
to detect a distinct peak of uaRNA in the mutant at 37oC in the metagene analysis. A 
small peak of uaRNA however was detected in about 10% of genes (Figures IV.5.A and 
IV.5.B). We believe that the inability to detect uaRNA signal in the mutant is due to the 
unstable nature of uaRNA. As mentioned before, uaRNA belongs to the category of 
ncRNAs called CUTs, which are extremely unstable and are immediately degraded by 
the yeast exosome. To understand the role of Clp1 in uaRNA synthesis, the GRO-Seq 
xperiments need to be repeated in Clp1 mutant strain that are deleted for the exosome 
component Rrp6. Deletion of Rrp6 will stabilize uaRNA in the Clp1 mutant. This strategy 
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was successfully used by the Proudfoot laboratory to determine the role of the Ssu72 
component of the CPF complex in uaRNA synthesis in budding yeast [7].  
Next, we examined the role of Clp1 in anti-sense transcription originating from 
the 3' end of genes. As mentioned above, we choose 634 genes for this analysis whose 
3' ends were at least 700 bp away from the neighboring gene. Alignment of GRO-Seq 
reads to the 3' end of these genes revealed robust anti-sense transcription in the Clp1 
mutant at 37oC (Figures IV.3 and IV.4). No such 3' end anti-sense transcript peak was 
observed either in the mutant at 25oC, or in the wild type strain at 37oC (Figures IV.3 
and IV.4). It is difficult to say if the 3' initiated anti-sense transcription is the cause or the 
consequence of the defective termination. It is, however, known that a number of 
inducible genes in yeast carry a promoter structure for anti-sense transcription at their 3' 
end [219]. Such promoters are the mirror images of the canonical promoter at the 5' end 
of genes. These antisense promoters are repressed when the gene is transcriptionally 
active, but get activated when the gene is inactive [217]. Thus, a number of inducible 
promoters in yeast exhibit 3' end initiated anti-sense transcription under non-inducible 
conditions. Upon induction of the gene, however, anti-sense transcription is completely 
inhibited. It has been proposed that when such 3' end initiated anti-sense transcripts 
reach the promoter element at the 5' end of gene, they somehow repress initiation of 
sense transcripts by a mechanism that is not yet fully understood. On the basis of these 
observations, we propose that under normal conditions, when termination is efficient, 
the 3' initiated anti-sense transcription is repressed. When the termination is defective, 
for example in the Clp1 mutant at 37oC, 3' initiated anti-sense transcription is activated. 
When the polymerase engaged in anti-sense transcription reaches the promoter region 
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of the gene, it tends to repress the initiation of transcription, resulting in an overall 
decrease in the transcription of the gene.  
Thus, both 5' end initiated and 3' end initiated anti-sense transcription tend to 
have an inhibitory effect on the sense transcription of the gene. An investigation into the 
mechanism of inhibition by anti-sense transcription will further contribute to our 
understanding of the biological role of anti-sense transcription in the cell.  
IV.3.3 Clp1 regulates promoter-associated sense transcription 
We have previously demonstrated that Clp1 affects reinitiation of transcription of 
the CHA1 and INO1 genes. A significant decrease in the density of RNAPII at the 
promoter region of both genes was observed in the Clp1 mutant at non-permissive 
temperature (Figure III.4). To determine if the Clp1 is required for promoter-associated 
sense transcription, we mapped the reads at the 5' end of genes in the Clp mutant at 
25oC and 37oC as described above.The results show about a 27% decrease in the 
GRO-Seq signal in the mutant following a temperature shift to 37oC (Figure IV.6). The 
mutant exhibited a decrease in promoter-associated polymerase even at 25oC (Figure 
IV.7). These results strongly suggest that the role of Clp1 in transcription is not limited to 
the 3' end of the gene, but extends to the 5' end of genes as well on genomewide scale.  
IV.3.4. Conclusion 
Genomewide analysis of the role of Clp1 in transcription revealed several 
important findings. First, the data showed that Clp1 is a general termination factor.  
Second, Clp1 may be bringing about termination by facilitating pausing of polymerase 
near the poly(A) signal as the terminator-proximal peak of polymerase was not 
observed in the clp1 mutant. This pausing of the polymerase is considered a 
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prerequisite for the termination of transcription. Third, Clp1-mediated termination of 
transcription represses the 3'-initiated antisense transcripts. This finding is in 
accordance with the previous studies that showed inhibition of 3’ initiated antisense 
transcription in the termination defective mutants. Fourth our data showed that Clp1 has 
an additional role in promoter-associated transcription. In the absence of a functional 
Clp1 protein, the density of transcriptionally active polymerase decreased by 27%. 
These results suggest that Clp1 is required for either initiation or reinitiation or both. 
Furthermore, Clp1 may also confer promoter directionality by limiting promoter initiated 
divergent transcription of upstream antisense RNA. Performing the GRO-Seq approach 
in an exosome mutant background will be required to investigate the role of this 
termination factor in inhibiting the 5'-initiated antisense transcription. Since Clp1 is 
essential for maintaining the integrity of the whole CFIA complex, these findings reflect 
the role of this complex rather than that of Clp1 alone.   
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APPENDIX A: EXPERIMENTAL PROCEDURES 
A.1. CELL CULTURE 
Cultures were started by inoculating 5 ml of YP-dextrose medium with colonies 
from a freshly streaked plate, and grown at 25°C overnight with constant shaking. Next 
morning, overnight grown cultures were diluted (1:100 dilution for the temperature-
sensitive strains, and 0.5:100 dilution for the wild type strains) to an appropriate volume 
and grown to OD600~0.4. The dilution was done in the appropriate synthetic complete-
drop out medium. Induction was done for 2 hrs at 25 °C before shifting the cells to 37 °C 
for another 2 hours for the deactivation step. Usually, this takes the cells to OD600 of 
about 0.7-0.8. At this stage, the cells are ready for processing for RT-PCR, 3C, ChIP, or 
TRO assays.                      
A.2. TRANSCRIPTION RUN-ON ASSAY (TRO)   
Transcription run-on (TRO) assay was performed by the modification of protocols 
described in Birse et al., 1997 and Hirayoshi  and Lis, 1999 [229,230]. For CHA1, WT 
and clp1-769-5 cells were grown in 100 ml of synthetic complete medium containing 
ammonium sulfate until A600 reached 0.4. Cells were centrifuged and resuspended in 
100 ml of synthetic media containing serine and threonine (1 g/l each) and induced for 2 
hours at 25oC.  50 ml of the cultures were centrifuged and resuspended in 50 ml of pre-
warmed (37oC) serine and threonine containing medium and deactivation was done at 
37oC for 120 minutes. The cell pellet obtained from 50 ml of liquid culture was washed 
with 10 ml cold TMN buffer (10 mM Tris-HCl pH 7.5, 5 mM MgCl2, 100 mM NaCl) and 
resuspended in 940 μl of DEPC (Diethylpyrocarbonate)-treated cold water.  To the cell 
suspension, 60 μl of 10% sarkosyl was added and incubation performed on ice for 25 
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min to permeabilize the cells. Permeabilized cells were recovered by a low-speed 
centrifugation (1.2xg, 6 minutes) and directly used in the run on transcription assay. 
Elongation of transcripts initiated in vivo was resumed by resuspending cells in 120 μl of 
2.5X reaction buffer (50 mM Tris-HCl pH 7.5, 500 mM KCl, 80 mM MgCl2, 5 mM DTT), 
45 μl of NTPs/RNase inhibitor mix (10 mM each of CTP, ATP, and GTP and 300 units of 
RNase Inhibitor), and 7 μl of [α-32P]-UTP (3000 Ci/mmol, 10 μCi/μl). The reaction mix 
was incubated at 30°C for 2 minutes to allow transcript elongation. The reaction was 
stopped by adding 1 ml of cold TMN buffer and quickly spun at low speed.  The 
recovered pellet was resuspended in 350 μl of Trizol.  About 250 l of acid-washed 
glass beads were added and the cells were lysed by vigorous shaking for 5 minutes on 
an agitator at room temperature. After lysis, tubes were spun for 5 minutes at 13800xg.  
To the recovered supernatant, 700 μl of Trizol and 200 μl of Chloroform were added 
and the samples were vigorously shaken on a vortexer, left on the bench for 5 minutes, 
and centrifuged at high speed for 10 minutes. 
To isolate RNA, the supernatant was extracted twice with phenol/chloroform (pH 
4.2). Labeled RNA was precipitated by adding 0.1 volumes of 10 M LiCl, 0.1 volumes of 
yeast tRNA (80 mg/ml) and 2.5 volumes of 100% ethanol. The mix was incubated at 
−20°C for 20 minutes followed by centrifugation at maximum speed for 15 minutes. The 
RNA pellet was resuspended in 60 μl of DEPC-treated water and denatured by adding 5 
μl of 2 M NaOH followed by incubation on ice for 5 minutes. The NaOH was then 
neutralized by adding 12 μl of sodium acetate/acetic acid mix (0.3 M sodium acetate pH 
5.2 and 0.5 μl of glacial acetic acid) and boiling the contents for 5 minutes.  
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In parallel, DNA probes of about 200-300 bp each in length, spanning the desired 
regions of the CHA1 gene, including the upstream and downstream regions, were 
obtained by PCR amplification (See Fig. 1A for the position of probes). 10 μg of probe 
was denatured by boiling in 0.1 N NaOH and 1 mM EDTA for 10 minutes to form single 
stranded DNA. The heat-denatured probes were then slot-blotted  a ZETA-probe GT 
membrane (BIO-RAD), according to manufacturer’s instructions. Adsorbed DNA was 
crosslinked to the membrane by baking at 80°C in a vacuum oven for 30 minutes. The 
membrane was then prehybridized with 10 ml of hybridization solution (0.5M potassium 
phosphate pH 7.2, 7% SDS) at 55°C for at least 30 minutes. The denatured RNA in 
hybridization solution from the step described above was added to the prehybridized 
membrane.  Labeled RNA was allowed to hybridize to the probe for 18-24 hours at 55°C 
in a rotator. After hybridization, the membrane was washed twice with 20 ml of a 
solution containing 0.1% SDS and 1XSSC for 7 minutes at 55°C, and twice with 20 ml 
of a solution containing 0.1% SDS and 0.1XSSC for 7 minutes at 55°C. After drying, the 
membrane was exposed to X-ray film overnight in an autoradiography cassette and the 
films were developed in a Kodak M35A X-OMAT system. All TRO signals were 
quantified using the GEL LOGIC 200 (KODAK) system and normalized with respect to 
the 18S control. 
A.3. CHROMATIN IMMUNOPRECIPITATION (ChIP) 
ChIP was performed as described in [120]. Primers used for ChIP-PCR are 
described appendix C. RNAPII ChIP was performed using anti-Rpb3 antibodies 
obtained from Santa Cruz (Cat# sc-101614). For ChIP analysis of CFI subunits Clp1, 
Rna14, Rna15 and Pcf11, a Myc-tag was inserted at the carboxy-terminus of each 
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subunit, and ChIP was performed using anti-Myc antibodies obtained from Upstate 
Biotechnology (Cat# 06-549). ChIP of TFIID was performed using anti-TBP antibodies 
obtained from Santa Cruz (Cat# sc-33736). ChIP analysis of TFIIB was carried out 
using anti-Myc antibodies in a strain with a C-terminus Myc-tagged TFIIB. For ChIP of 
TFIIF, TFIIE and TFIIH, strains were constructed with a TAP-tag inserted at the 
carboxy-terminus of Tfg2, Tfa2, and Ccl1 subunits respectively, and ChIP was 
performed using IgG-Sepharose beads.  
Crosslinking, cell lysis and isolation of chromatin was done as described in [120].  
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A.4. CHROMOSOME CONFORMATION CAPTURE ANALYIS (3C) 
3C experiments were performed exactly as described previously [120]. The 
primers used for 3C analysis are shown in supplemental Table S2. A 50 ml cell culture 
was grown as described above. Cells were formaldehyde crosslinked for 15 minutes at 
25°C. The crosslinked crude chromatin was digested with restriction endonuclease(s) 
(Alu1 for INO1; NlaIV and Alu1 for CHA1). After restriction digestion, the reaction 
volume was diluted by 7.5 fold to minimize intermolecular ligation in the next step. 
Ligation reactions were performed at room temperature for 90 minutes. The crosslinks 
were reversed by incubating at 65°C overnight. DNA was extracted with phenol-
chloroform followed by ethanol precipitation. 500 ng of DNA was used as template in 
the PCR using the P1-T1 divergent primer pair as indicated in Figures II.3 A, III.12.A 
and D. Control PCR products were generated using a convergent primer pair (F2-R1). 
PCR and detection of products were performed exactly as described in [120]. Each 
experiment was performed with at least four independently grown cultures. The P1-T1 
PCR signals are normalized with respect to F2-R1 PCR signals. The main steps in the 
CCC approach are shown in Figure A.1. 
A.5. TRANSCRIPTION ANALYSIS (RT-PCR) 
Isolation of total RNA and transcription analysis was performed by RT-PCR using 
oligo-dT primer at the reverse transcription step as described previously (El Kaderi et al 
2009). The RT-PCR primers are shown in appendix C. A minus-RT control (without 
reverse transcriptase) was always performed to ensure that the RT-PCR signal was not 
coming from contaminating DNA. The RT-PCR results were normalized with respect to 
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the 18S rRNA control that is transcribed by RNAP I and requires a different set of 
transcription factors.  
A.6. STRAND-SPECIFIC RT-PCR  
Strand-specific RT-PCR was performed to distinguish between sense and anti-
sense transcripts. Total RNA for this procedure was extracted using Trizol reagent. The 
cell pellet was resuspended in 500 μl of Trizol. Acid-washed glass beads (about 250 μl) 
were added to the cell suspension. Cells were lysed by vigorous shaking for 10 minutes 
on an agitator at 4oC. Whole cell lysate was recovered by puncturing the bottom of the 
tube with a 22-guage needle, placing it on the top of a 15 ml pre-chilled centrifuge tube 
and centrifuging at 300xg for 2 minutes. The filtrate was transferred into a chilled 1.5 ml 
microfuge tube and 500 μl more Trizol reagent was added. After adding 200 μl of 
chloroform, tubes were vigorously agitated and left on the bench for 5 minutes. The 
tubes were then centrifuged at high speed for 10 minutes. The supernatant was 
extracted two times with an equal volume of phenol/chloroform (pH 4.3), followed by an 
extraction with chloroform only. RNA was precipitated using 0.1 volumes 10 M LiCl and 
3 volumes cold ethanol in the presence of glycogen as a carrier. The precipitated RNA 
was collected by centrifugation at 14220xg on a table-top centrifuge for 15 minutes. The 
air-dried RNA pellet was resuspended in 50 μl of DEPC-treated water and the 
concentration was estimated using a spectrophotometer.  
Strand specific RT-PCR was now performed as described in [120]. 1μg of RNA 
was used to make cDNA using strand-specific primers for CHA1 as shown in Figure 2A. 
Primers As, Bs, Cs and Ds were used to reverse-transcribe sense mRNA, while Aas, Bas 
and Cas primers were used for reverse transcription of anti-sense transcripts. This was 
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followed by PCR amplification of cDNA for regions W, X, Y and Z using primer pairs Aas-
Bs, Aas-As, Bas-Cs and Cas-Ds respectively.  A minus-RT control (without reverse 
transcriptase) was always performed to ensure that the strand-specific RT-PCR signal 
was not due to contaminating DNA in the RNA preparation. RT-PCR results were 
normalized with respect to the 18S rRNA control that is transcribed by RNAP I and 
requires a different set of transcription factors.  
A.7. IMMUNOPRECIPITATION-WESTERN BLOT 
Immunoprecipitation was performed using C-terminal Myc-tagged strains for 
TFIIB, Pcf11, Rna14, Rna15, and clp1 proteins (NAH20, NAH22, NAH21, NAH25, and 
NAH29, respectively) constructed in the clp1 mutant background. The Myc-tag was 
amplified from pFA6a-13-myc-trp and inserted at the C-terminus of these subunits by 
one-step PCR-based chromosome modification.   
A.7.1 GROWING CELLS AND OPTAINIG CHROMATIN  
 Freshly streaked plates were used to inoculate 5 ml of YP-Dextrose media and 
the cells were grown for 6 hours with shaking at 25°C. These cultures were diluted 1: 
100 in 300 ml of YPD and left to grow at 25°C with shaking till A600 reached 0.8. The 
cultures were then split into two halves of 150 ml each and centrifuged at 3000 rpm for 
5 minutes. Cell pellet from each half was resuspended in 150 ml of pre-warmed (37oC) 
YPD medium.  For deactivation, the cells in the pre-warmed media were incubated at 
37oC for 2 hours. The other cell pellet from 150 ml culture was left at 25oC for 2 hours. 
This step normally takes cells to an A600 of ~1.2. Equal O.D. units of the cultures were 
pelleted by centrifugation at 3000 rpm for 5. Upon the deactivation period, the cells were 
pelleted and washed once with 50 ml of cold water and pelleted again. The cell pellets 
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were flash frozen in liquid nitrogen, thawed by resuspending in 500 μl of IP lysis buffer 
supplied with1mM PMSF).  The cells were lysed for 1 hour using ~ 300 μl of glass 
beads and vigorous shacking at 4oC. The cell lysates were then centrifuged at 4°C 
(14000 rpm for 15 minutes). The supernatants were subjected to immunoprecipitation 
using anti Myc antibodies conjugated beads and western blots were conducted as in 
Medler et al., 2011.  
A.8. GRO-Seq  
A.8.1 PREPARATION OF CELLS  
Nuclear run-on reaction and the library construction for GRO-Seq were 
performed as described in Birse et al., 1997 and Core et al., 2012 with some 
modifications. The wild type (W303-1a) and the clp1 769-5 mutant cells were grown at 
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25oC in 100 ml of Yeast extract-Peptone-Dextrose (YPD) medium till A600 reached 0.4. 
The cultures were then split into two halves of 50 ml each; transferred to 50 ml sterile 
tubes; and centrifuged at 3000 rpm for 5 minutes. Cell pellet from one tube was 
resuspended in 50 ml of pre-warmed (37oC) YPD medium.  For deactivation, the cells in 
the pre-warmed media were incubated at 37oC for 2 hours. The other cell pellet from 50 
ml culture was left at 25oC for 2 hours. This step normally takes cells to an A600 of ~ 0.8. 
Equal O.D. units of the cultures were pelleted by centrifugation at  3000 rpm for 5 
minute at 4oC. Cell pellets were washed with 10 ml of ice-cold TMN buffer (10 mM Tris-
HCl pH 7.5, 5 mM MgCl2, 100 mM NaCl); left in the buffer for 10 minutes; centrifuged at 
3000 rpm for 5 minutes; and then resuspended in 940 μl of DEPC 
(Diethylpyrocarbonate)-treated ice-cold water. Chilling cells to ~ 4oC at this stage is 
essential for stopping any residual transcription. The cell suspensions were transferred 
to a pre-chilled eppendorf tubes, and 60 μl of 10% sarkosyl was added to the cell 
suspension. The tubes were tightly sealed with parafilm and placed inside a 50 ml tubes 
backed with ice. The samples were incubated for 25 minutes on a nutator at 4oC to 
permeabilize cells. Sarkosyl is an anionic detergent that permeabilizes yeast cells and 
prevents any new initiation events by inhibiting the PIC assembly. Sarkosyl, however, 
does not interfere with the stability of preassembled PIC, and the catalytic activity of the 
polymerase molecules. The permeabilized cells were recovered by a low-speed 
centrifugation at 3600 rpm for 6 minutes at 4oC. The supernatant was quickly and 
thoroughly aspirated out to remove the endogenous nucleotides. The remaining pellet 
was then kept in ice till use in the run on transcription reaction.  
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A.8.2. NUCLEAR RUN-ON REACTION 
During the run-on reaction, the transcription events initiated in vivo are allowed to 
resume elongation by supplying the permeabilized cells with the nucleotides containing 
buffer, and incubating the reaction at 30OC. In the run-on buffer UTP was replaced with 
the bromo-UTP nucleotides. Therefore, all the new transcription is done by RNA 
polymerase molecules that were already engaged in transcription before harvesting the 
cells and all the newly synthesized transcripts will contain Br-UTP nucleotide. For each 
run-on reaction, the cell pellet was thoroughly resuspended in 150 μl of run-on reaction 
buffer (50 mM Tris-HCl pH 7.5, 100 mM KCl, 10 mM MgCl2, 2 mM DTT, 0.5 mM each of 
(ATP, CTP, GTP and BrUTP) and 5 μl RNase Inhibitor. The reaction mixture was 
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incubated in 30°C water bath for 5 minutes with gentle inversion of tubes every 2 
minutes to allow elongation of the transcripts.  The reactions were immediately stopped 
by adding 500 μl of ice-cold Trizol reagent (Ambion). The efficiency of Br-UTP 
incorporation was assessed by performing a TRO assay for ASC1 (Figure A.2) 
A.8.3. EXTRACTION OF TOTAL RNA  
 
 About 250 μl of acid-washed glass beads were added to the run-on reaction and 
the cells were lysed by vigorous agitation at room temperature for 5 minutes.  The 
samples were recovered by puncturing the bottom of the tubes using a red hot 22g 
needle; placing them in 15 ml falcon tubes; and spinning at 1500 rpm for 2 minutes at 
4°C. Recovered filtrate was transferred to pre-chilled 1.5 ml eppendorf tubes.  An 
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additional 500 μl of Trizol and 200 μl of chloroform were added to the tubes, and the 
samples were vigorously agitated. After incubation at room temperature for 5 min, 
samples were vigorously shaken again followed by centrifugation at 14000 rpm for 10 
minutes. The upper aqueous phase was carefully transferred to another tube while 
taking care that the precipitated DNA in the interphase is left untouched. Three 
consecutive acid phenol-chloroform extractions followed by a chloroform only extraction 
were performed to further purify the RNA. Total RNA was precipitated in 0.3 M NaCl 
and 3 volume of ice-cold 100% ethanol. 2 μl of glycogen was added as a carrier. The 
mixture was incubated at −20°C for 60 min followed by centrifugation at 13200 rpm for 
30 minutes at 4°C. RNA pellet was washed once with 1 ml of ice-cold 75% ethanol and 
centrifuged for another 10 minutes. The resultant RNA pellet was air dried for 5 minutes 
and resuspended in 55 μl of DEPC-treated water. RNA integrity was assessed by 
running 5 μl of each RNA sample on a 8% denaturing polyacrylamide gel (8% 
polyacrylamide, 7M urea, 1X TBE buffer) (Figure A.3.). The RNA purity was also 
assessed by measuring the RNA absorbance at 260 nm using nanodrop 
spectrophotometer (Figure A.4).  
A.8.4 RNA HYDROLYSIS  
To improve resolution, the RNA samples were subjected to a partial hydrolysis 
using NaOH. RNA hydrolysis was performed by adding 5 μl of 1N NaOH (f.c. 500 mM), 
mixing thoroughly and placing in ice for 20 minutes. NaOH was neutralized by adding 
30 μl of 1M Tris-HCl (pH 6.6) (Figure A.5.). Samples were purified using Rneasy kit 
(Qiagen) to remove any unincorporated BrUTP nucleotides and to change buffer 
composition. Samples were eluted from the Rneasy columns in a final volume of 100 μl 
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of DEPC-treated water. The RNA samples were incubated at 65°C for 5 minutes and 
immediately placed on ice till ready for binding to the BrUTP antibody conjugated beads 
(Santa Cruz). 
A.8.5 IMMUNOPURIFICATION OF NASCENT RNA  
The nascent nuclear run on transcripts (NRO-RNA) represent a small fraction of 
the total RNA isolated in the preceding step. The Br-UTP nucleotides incorporated in 
the nascent transcripts serve as the affinity tag for the purification nascent RNA. In 
parallel, 100 μl slurry of BrdUTP antibody-conjugated beads were prepared for each 
sample. The beads were transferred to a clean eppendorf tube and washed three times 
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each with 500 μl of the binding buffer (0.25X SSPE buffer, 1mM EDTA, 0.05% Tween, 
37.5 mM NaCl). The washed beads were resuspended in 500 μl of blocking buffer (1X 
binding buffer, 0.1 PVP (polyvinylpyrrolidone),1 μg/ ml Ultra Pure BSA) and the tubes 
were incubated at 4°C on a nutator for two hours. The blocked beads were washed 
twice with the binding buffer and resuspended in another 400 μl of the same buffer. The 
RNA samples prepared previously were bound to the beads at 4°C nutator for one hour.  
Upon binding, the beads were washed consecutively with 500 μl of binding buffer, low 
salt buffer (0.2X SSPE buffer, 1mM EDTA, 0.05% Tween), and high salt buffer (0.25X 
SSPE buffer, 1mM EDTA, 0.05% Tween,100 mM NaCl) once each. This was followed 
two washes each of 500 μl TET buffer (10 mM Tris-HCl pH 7.5, 1mM EDTA. 0.5% 
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Tween). All the washes were done on nutator for three minutes each. All the 
centrifugation steps between the washes were at 1500 rpm for 1 minute each, with 
incubation of tubes on ice for 30 seconds before aspirating out the wash buffer. The 
nascent RNA transcripts were eluted two times each with 125 μl and one time with 250 
μl of elution buffer (20 mM DTT, 150 mM NaCl,  50 mM Tris-HCl pH 7.5, 1 mM EDTA, 
0.1% SDS) for a total elution time of 10 minutes in 42°C water bath. RNA was 
precipitated in 0.3 M NaCl and 3 volume of ice-cold 100% ethanol and 2 μl of glycogen 
as a carrier. The samples were incubated at −20°C for 60 min followed by centrifugation 
(13200 rpm for 30 minutes) at 4°C. RNA pellets were washed with ice-cold 75% ethanol 
and centrifuged for another 10 minutes. The pellets were air dried for 5 minutes and 
resuspended in 12 μl of DEPC-treated water. 2 μl of each sample was run in 8% 
denaturing polyacrylamide gel to check the binding of samples to the BrdUTP antibody 
conjugated beads (Figure A.6).  
A.8.6. rRNA DEPLETION 
GRO-Seq libraries were constructed using the ScriptSeqTM complete Kit 
(epicenter). The nascent, purified RNA samples were first depleted of rRNA. The 
depletion of rRNA was performed as recommended by the Ribo-Zero™ Magnetic Kit 
(epicentre). 5 μg of each RNA sample was combined with 10 μl of rRNA removal 
solution and 4 μl of reaction buffer in a 40 μl reaction volume. The mixture was gently 
mixed and incubated in 68 °C water bath for 10 minutes followed by incubation at room 
temperature for 5 minutes. In parallel, 225 μl (per sample) of magnetic beads 
suspension was processed. The bead suspension was transferred to a 1.5 ml RNase-
free tube and placed in a magnetic stand for 2 minutes. After aspirating out the clear 
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phase, the tubes were removed from the stand and the beads were washed two times 
each with 225 μl of RNase-Free water. Each time, the tubes were placed in the 
magnetic stand for 2 minutes before removing the supernatant. The washed beads 
were resuspended thoroughly in 65 μl of Resuspension Solution supplied with 1 μl of 
RiboGuard RNase Inhibitor. The previously treated RNA mixture was added to the 
processed beads and they were mixed immediately by quick pipetting followed by brief 
and gentle agitation. The mix was incubated at room temperature for 5 minutes, 
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agitated briefly, and incubated in 50°C water bath for 5 minutes. The tubes were 
immediately placed in the magnetic stand for 2 minutes before the transfer of the 
supernatant (~ 90 μl of rRNA-depleted sample) to a new RNase-Free tube. The volume 
of the rRNA depleted samples was adjusted to 180 μl with RNase-Free water. Samples 
were ethanol precipitated by adding 18 μl of 3M sodium acetate, 2 μl of glycogen, and 
600 μl of ice-cold 100% ethanol, mixed thoroughly and placed in -20°C for 2 hours. 
Tubes were centrifuged at 13200 rpm for 30 minutes at 4°C, and pellets were washed 
once with ice-cold 75% ethanol and centrifuged for another 10 minutes. RNA pellets 
were air dried for 5 minutes and resuspended in 10 μl of DEPC-treated water each. 
Aliquots of the rRNA-depleted samples were run in 8% denaturing polyacrylamide gel to 
assess the depletion efficiency (Figure A.6.). 
A.8.7. LIBRARY PREPARATION  
Construction of the final library was done in six sequential steps. First, 2 μl of the rRNA 
depleted samples were fragmented in a 12 μl reaction volume containing 1 μl of RNA 
Fragmentation Solution and 2 μl of cDNA Synthesis Primer. The components were 
mixed carefully and incubated in thermocycler for 5 minutes at 85°C before placing on 
ice.  Second, the fragmented RNA samples were reverse transcribed and 5' tagged. 
This was done by combining 3 μl of cDNA Synthsis PreMix, 0.5 μl of 100mM DTT and 
0.5 μl StarScrip Reverse Transcriptase in a 0.2 ml tube, mixing carefully and adding the 
mix to the fragmented RNA sample and mixing the whole sample properly. The tubes 
were placed in a thermocycler and incubated at 25°C for 5 minutes followed by 42°C for 
20 minutes. The tubes were cooled to 37°C before adding 1 μl of Finishing Solution and 
incubating at 37°C for 10 minutes. The tubes were incubated at 95oC for 3 minutes to 
99 
 
 
 
stop the reaction. The tubes were then incubated at 95°C for 3 minutes, cooled and 
then kept at 25°C. Third, the cDNA samples were 3' terminal–tagged by thoroughly 
mixing 7.5 μl Terminal Tagging Premix and 0.5 μl of DNA polymerase in a 0.2 ml tube 
and adding the mix to the cDNA samples from the previous step and mixing all well. The 
reactions were incubated in a thermocycler for 15 minutes at 25°C followed by 3 
minutes at 95°C after which the reactions were cooled to 4°C. Fourth, the terminal 
tagged cDNA samples were purified using Qiagen MinElute PCR purification kit and 
eluted with 25 μl of the provided elution buffer. Normally, the sample volume recovered 
from this elution step is 22.5 μl. Fifth, all the purified cDNA samples were used in the 
final PCR amplification reactions. Briefly, in a 50 μl reaction volumes, 22.5 μl samples 
were combined with 5 μl of advantage buffer, 1 μl of advantage polymerase, 1 μl of the 
provided Forward PCR primer, 1 μl of the ScriptSeq Index PCR primer, for barcoding, 
(epicentre) and 1 μl of dNTP mix. For sample multiplexing, ScriptSeq Index PCR primer 
#1, #6, and #12 were used for barcoding the wildtype cells, Clp1mutant cells grown at 
the permissive temperature (25°C), and Clp1 mutant cells  grown at the restrictive 
temperature (37°C), respectively. In a thermocycler, the reactions were incubated at 
95°C for 1 minute followed by 15 cycles of 95°C for 30 seconds, 55°C for 30 seconds 
and 68°C for 3 minutes. The reactions were then incubated at 68°C for 7 minutes for the 
final extension step. Finally, the libraries were subjected to a final purification step using 
the Qiagen MinElute PCR purification kit. Each library was eluted in 30 μl elution buffer 
of which 3 μl were ran in a 1.5% agarose gel  for the quality check and 1 μl was used for 
the optical density reading (Figure A.5.). A flow chart for the main steps in the GRO-Seq 
protocol is shown in Figure A.6. 
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A.9. QUANTIFICATION 
The quantification was performed as described in [214].  
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APPENDIX B: STRAINS 
B.1. STRAINS USED IN CHAPTER II 
 
B.2. STRAINS USED IN CHAPTER III 
Strain  Genotype Reference 
H-144 (W303 1A) MATa leu2-3 can1-100 ura3-1 ade2-1 
his3-11,15 trp1-1 
 
WZ8 (hrp1-5) MATα cup1Δ ura3 his3 trp1 lys2 ade2 
leu2 hrp1::HIS3[pRS315-hrp1-L205S 
(LEU2 
Kuehner and Brow, 2008 
H-264 (pap1-1) MAT ade1/ade2 lys2 ura3-52 pap1-1 
 
Claire Moore, 2006 
H-261 (rna14-1) MAT ura3-1 trp1-1 ade2-1 leu2-3,112 
his3-11,15 rna14-1 
Claire Moore, 2002 
    Strain Genotype    Reference 
By4733 MATa his3200 trp163 leu20 met150 ura30  
Clp1- 769-5 MATa ura3Δ0 leu2Δ0 his3Δ1lys2Δ0can1Δ::LEU2-
MFA1pr::His3 clp1ts::URA3 
Ben-Aroya S, 
et al.  (2008) 
SAM53 BY4733, MATa his3200 trp163 leu20 met150 
ura30 CLP1-Myc(trp) 
Medler et al., 
2011 
NAH20 MATa ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0can1Δ::LEU2-
MFA1pr::His3 clp1-ts::URA3.SUA7(TFIIB)-Myc-KMX 
 
This study 
NAH21 MATa ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0can1Δ::LEU2-
MFA1pr::His3 clp1-ts::URA3  Rna14-Myc-KMX 
This study 
NAH22 MATa ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0can1Δ::LEU2-
MFA1pr::His3 clp1-ts::URA3 Pcf11-Myc-KMX 
This study 
NAH25 MATa ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0can1Δ::LEU2-
MFA1pr::His3 clp1-ts::URA3 Rna15-Myc-KMX 
 
This study 
NAH26 
 
MATa ura3Δ0 leu2Δ0 his3Δ1lys2Δ0can1Δ::LEU2-
MFA1pr::His3 clp1ts::URA3 Trp1 Δ (KMX) 
This study 
NAH29 
 
MATa ura3Δ0 leu2Δ0 his3Δ1lys2Δ0can1Δ::LEU2-
MFA1pr::His3 clp1ts::URA3 Trp1 Δ Clp1-Myc (TRP) 
This study 
NAH31 MATa ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0can1Δ::LEU2-
MFA1pr::His3 clp1-ts::URA3 CCL1-TAP (TRP) 
This study 
NAH32 MATa ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0can1Δ::LEU2-
MFA1pr::His3 clp1-ts::URA3 TFA2-TAP (TRP) 
This study 
NAH33 MATa ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0can1Δ::LEU2-
MFA1pr::His3 clp1-ts::URA3 TFG2-TAP (TRP) 
This study 
NAH36 MATa his3200 trp163 leu20 met150 ura30  TFA2- 
TAP (TRP) 
This study 
NAH37 MATa his3200 trp163 leu20 met150 ura30  CCL1- 
TAP (TRP) 
This study 
NAH38 MATa his3200 trp163 leu20 met150 ura30  TFG2- 
TAP (TRP) 
This study 
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B.3. STRAINS USED IN CHAPTER IV 
 
B.4. STRAIN CONSTRUCTION 
SAM53, which contained the Myc-tag at the carboxy-terminal of Clp1 in BY4733 
strain background, was constructed by transforming the parental strain with the PCR 
product amplified from pFA6-13Myc-TRP1. The temperature-sensitive mutant clp1-769-
5 was kindly provided by Dr. Philip Hieter. Strains NAH20, NAH21, NAH22, NAH31, 
NAH32 and NAH33 were derived from the temperature sensitive clp1-769-5 strain by 
adding either the Myc or the Tap-tag at the carboxy terminus of an initiation factor or a 
termination factor. Strains NAH20 (Myc-tagged TFIIB), NAH21 (Myc-tagged Rna14), 
NAH22 (Myc-tagged Pcf11) and NAH25 (Myc-tagged Rna15), which contained the Myc-
tag at the carboxy-terminus of the indicated factor, were constructed by transforming the 
clp1-769-5 strain with the PCR product amplified from pFA6-13Myc-KanMX6. For TAP-
tagging of the general transcription factors, first the temperature-sensitive clp1-769-5 
strain was made trp1- by replacing TRP1 with a KanMX cassette that was PCR 
amplified from pUG6. Next a TAP-tag was inserted at the carboxy-terminus of TFIIH 
subunit Ccl1 (NAH31), TFIIF subunit Tfg2 (NAH33) and TFIIE subunit Tfa2 (NAH32) by 
transforming the clp1-769-5-(trp1) strain with the TAP-cassette amplified from plasmid 
pBS1479. NAH29 was constructed by deleting the TRP1 gene from the temperature 
sensitive clp1-769-5 strain by one step gene replacement using a PCR product 
Strain  Genotype Reference 
 
By4733 MATa his3200 trp163 leu20 met150 
ura30 
 
clp1- 769-5 MATa ura3Δ0 leu2Δ0 his3Δ1lys2Δ0 
can1Δ::LEU2-MFA1pr::His3 clp1ts::URA3 
Ben-Aroya S, et al.  
(2008) 
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containing KanMX amplified from pUG6. KanMX was then excised out utilizing the CRE 
recombinase activity and the resultant strain was transformed with the PCR product 
amplified from pFA6-13Myc-TRP1 to insert the Myc-tag at the carboxy-terminus of clp1. 
Strains NAH36 (TAP-tagged Tf2a), NAH37 (TAP-tagged Ccl1), and NAH38 (TAP-
tagged Tfg2), which contained the Myc-tag at the carboxy-terminus of the indicated 
factor in BY4733 strain background, was constructed by transforming the parental strain 
with the PCR product amplified from pFA6-13Myc-TRP1. 
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APPENDIX C: PRIMERS 
C.1. CHA1 TRO-PRIMERS 
Name                                      Sequence 
CHA1 A GATAGCCTCTTGCGACCTTATT 
 CTTAACAGGAGCCGCCCAT 
CHA1 B GCCCCAGCGGAAATGTAA 
 CATTCATATTTCAAGAAAAATTGTG 
CHA1 C GCGATGAGATAAGATAAAAGGGA 
 GATTACCGATTCCTCTACTTTTGA 
CHA1 D AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 E GTTGGTGGAGGTGGTTTATACA 
 TCTGGTGTTGTATTTGCGAGC 
CHA1 F GGTGGAAACGAATGGATGTC  
 TCTTAGTGTTGTAACCCAAATGC 
CHA1 G GGAAGAAGCGTTGGATAGCAT 
 CGTTTTGGATATGTTGATGCTTAC 
CHA1 H GCACAGAATTTGTATAAAGGGG 
 GCTTTTCTTCACTTAGTAAGGATTAA 
CHA1 I GTTCCGTAATAATCTTCCCAGC 
 CTGGGGTCTTCATTTGTGTCA 
 
C.2. ChIP-PRIMERS 
 
INO1 RNAPII-ChIP 
    Name                                      Sequence 
INO1 A GAAATATGCGGAGGCCAAG 
 GGAGGTGATTGGAGCAATATTATC 
NO1 B GCTTGTTCTGTTGTCGGGTTC 
 TCTTCGTAACTACAGCATTTTCG 
NO1 C GTATTAAACCGGTCTCCATTGC 
 CCGACGGGCTTCATATATTTG 
NO1 D GATATCCAGAATTTCAAAGAAGAAAAC 
 TATTCTGCGGTGAACCATTAATATAG 
NO1 E CTCATTTCAACGACTCTCTTTTTC 
 ATGTTAAGTATATGTATTGATGGAAGG 
NO1F GGTAGATGCGAGAAAGTGCTG 
 CTTCTTTCTCGTCCTCCTCCT 
CHA1 A GCCCCAGCGGAAATGTAA 
 GATTACCGATTCCTCTACTTTTGA 
CHA1 B AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 C GGTGGAAACGAATGGATGTC 
 TCTTAGTGTTGTAACCCAAATGC 
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CHA1- TFIIB –ChIP 
    Name                                         Sequence                      
CHA1 A GATAGCCTCTTGCGACCTTATT 
 CATTCATATTTCAAGAAAAATTGTG 
CHA1 B AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 C GGTGGAAACGAATGGATGTC 
 TCTTAGTGTTGTAACCCAAATGC 
CHA1 D GGAAGAAGCGTTGGATAGCAT 
 CCCCTTTATACAAATTCTGTGC 
 
INO1 TFIIB-ChIP 
    Name                                         Sequence                      
INO1 A GCTTGTTCTGTTGTCGGGTTC 
 GGAGGTGATTGGAGCAATATTATC 
INO1 B GATATCCAGAATTTCAAAGAAGAAAAC 
 TATTCTGCGGTGAACCATTAATATAG 
INO1 C GTATTAAACCGGTCTCCATTGC 
 CCGACGGGCTTCATATATTTG 
INO1 D CTCATTTCAACGACTCTCTTTTTC 
 GCACTTTCTCGCATCTACCTCA 
 
CHA1-TBP –ChIP 
    Name                                         Sequence                      
CHA1 A GCGATGAGATAAGATAAAAGGGA 
 GATTACCGATTCCTCTACTTTTGA 
CHA1 B AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 C GGTGGAAACGAATGGATGTC 
 TCTTAGTGTTGTAACCCAAATGC 
CHA1 D GGAAGAAGCGTTGGATAGCAT 
 CGTTTTGGATATGTTGATGCTTAC 
 
INO1 TBP-ChIP 
    Name                                         Sequence                      
INO1 A GCTTGTTCTGTTGTCGGGTTC 
 GGAGGTGATTGGAGCAATATTATC 
INO1 B GATATCCAGAATTTCAAAGAAGAAAAC 
 TATTCTGCGGTGAACCATTAATATAG 
INO1 C GTATTAAACCGGTCTCCATTGC 
CHA1 D GGAAGAAGCGTTGGATAGCAT 
 CCCCTTTATACAAATTCTGTGC 
CHA1 E GCACAGAATTTGTATAAAGGGG 
 GCTTTTCTTCACTTAGTAAGGATTAA 
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 CCGACGGGCTTCATATATTTG 
INO1 D CTCATTTCAACGACTCTCTTTTTC 
 GCACTTTCTCGCATCTACCTCA 
 
CHA1-TFIIE-ChIP 
    Name                                        Sequence 
CHA1 A GCGATGAGATAAGATAAAAGGGA 
 GATTACCGATTCCTCTACTTTTGA 
CHA1 B AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 C GGTGGAAACGAATGGATGTC 
 TCTTAGTGTTGTAACCCAAATGC 
CHA1 D GGAAGAAGCGTTGGATAGCAT 
 CCCCTTTATACAAATTCTGTGC 
 
INO1 TFIIE-ChIP 
    Name                                        Sequence 
INO1 A GAAATATGCGGAGGCCAAG 
 GGAGGTGATTGGAGCAATATTATC 
INO1 B GATATCCAGAATTTCAAAGAAGAAAAC 
 TATTCTGCGGTGAACCATTAATATAG 
INO1 C GTATTAAACCGGTCTCCATTGC 
 CCGACGGGCTTCATATATTTG 
INO1 D CTCATTTCAACGACTCTCTTTTTC 
 GCACTTTCTCGCATCTACCTCA 
 
CHA1- TFIIH-ChIP            
    Name                                             Sequence 
CHA1 A GCGATGAGATAAGATAAAAGGGA 
 GATTACCGATTCCTCTACTTTTGA 
CHA1 B AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 C GGTGGAAACGAATGGATGTC 
 TCTTAGTGTTGTAACCCAAATGC 
CHA1 D GGAAGAAGCGTTGGATAGCAT 
 GGAAAAAATCAATACTAGCAAAATA 
 
INO1 TFIIH-ChIP 
    Name                                             Sequence 
INO1 A GCTTGTTCTGTTGTCGGGTTC 
 TCTTCGTAACTACAGCATTTTCG 
INO1 B TATTCTGCGGTGAACCATTAATATAG 
 GTATTAAACCGGTCTCCATTGC 
INO1 C GTATTAAACCGGTCTCCATTGC 
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 CCGACGGGCTTCATATATTTG 
INO1 D GACAAAGAGGCAATAGTTCAAAAG 
 CTCATTTCAACGACTCTCTTTTTC  
 
CHA1-TFIIF-ChIP 
    Name                                             Sequence 
CHA1 A GCGATGAGATAAGATAAAAGGGA 
 GATTACCGATTCCTCTACTTTTGA 
CHA1 B AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 C GGTGGAAACGAATGGATGTC 
 TCTTAGTGTTGTAACCCAAATGC 
CHA1 D GGAAGAAGCGTTGGATAGCAT 
 GGAAAAAATCAATACTAGCAAAATA 
 
INO1-TFIIF-ChIP 
    Name                                             Sequence 
INO1 A GAAATATGCGGAGGCCAAG 
 GGAGGTGATTGGAGCAATATTATC 
INO1 B GATATCCAGAATTTCAAAGAAGAAAAC 
 TATTCTGCGGTGAACCATTAATATAG 
INO1 C GTATTAAACCGGTCTCCATTGC 
 CCGACGGGCTTCATATATTTG 
INO1 D CTCATTTCAACGACTCTCTTTTTC 
 GCACTTTCTCGCATCTACCTCA 
 
CHA1-Clp1p-Myc-ChIP 
    Name                                        Sequence 
CHA1 A GCGATGAGATAAGATAAAAGGGA 
 GATTACCGATTCCTCTACTTTTGA 
CHA1 B AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 C GGTGGAAACGAATGGATGTC 
 TCTTAGTGTTGTAACCCAAATGC 
CHA1 D GGAAGAAGCGTTGGATAGCAT 
 CCCCTTTATACAAATTCTGTGC 
 
INO1-Clp1p-Myc-ChIP 
    Name                                        Sequence 
INO1 A GAATATTGAACTTATTTAATTCACATGG 
 GGAGGTGATTGGAGCAATATTATC 
INO1 B GTATTAAACCGGTCTCCATTGC 
 CCGACGGGCTTCATATATTTG 
INO1 C GATATCCAGAATTTCAAAGAAGAAAAC 
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 TATTCTGCGGTGAACCATTAATATAG 
INO1 D CTCATTTCAACGACTCTCTTTTTC 
 ATGTTAAGTATATGTATTGATGGAAGG 
 
CHA1-Rna14-TAP-ChIP 
    Name                                        Sequence 
CHA1 A GCCCCAGCGGAAATGTAA 
 CATTCATATTTCAAGAAAAATTGTG 
CHA1 B AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 C GTTGGTGGAGGTGGTTTATACA 
 TCTTAGTGTTGTAACCCAAATGC 
CHA1 D GGAAGAAGCGTTGGATAGCAT 
 CGTTTTGGATATGTTGATGCTTAC 
 
INO1-Rna14-TAP-ChIP 
    Name                                        Sequence 
INO1 A GCTTGTTCTGTTGTCGGGTTC 
 GGAGGTGATTGGAGCAATATTATC 
INO1 B GATATCCAGAATTTCAAAGAAGAAAAC 
 TATTCTGCGGTGAACCATTAATATAG 
INO1 C GTATTAAACCGGTCTCCATTGC 
 CCGACGGGCTTCATATATTTG 
INO1 D CTCATTTCAACGACTCTCTTTTTC 
 GCACTTTCTCGCATCTACCTCA 
 
CHA1-Rna15-TAP-ChIP 
    Name                                        Sequence 
CHA1 A GCGATGAGATAAGATAAAAGGGA 
 GATTACCGATTCCTCTACTTTTGA 
CHA1 B AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 C GGTGGAAACGAATGGATGTC 
 TCTTAGTGTTGTAACCCAAATGC 
CHA1 D GGAAGAAGCGTTGGATAGCAT 
 CCCCTTTATACAAATTCTGTGC 
 
INO1-Rna15-TAP-ChIP 
    Name                                        Sequence 
INO1 A GAAATATGCGGAGGCCAAG 
 GGAGGTGATTGGAGCAATATTATC 
INO1 B GATATCCAGAATTTCAAAGAAGAAAAC 
 TATTCTGCGGTGAACCATTAATATAG 
INO1 C GTATTAAACCGGTCTCCATTGC 
 CCGACGGGCTTCATATATTTG 
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CHA1-Pcf11-TAP-ChIP 
 
INO1-Pcf11-TAP-ChIP 
 
CHA1-Strand-Specific RT-PCR primers 
    Name                                        Sequence 
Aas CGAGTACTAATCACCGCGAAC 
Bas AATTCAAAAGGACGGTAAAAGAT 
Cas GGAAGAAGCGTTGGATAGCAT 
As AAGAGAAAACTGTATAAACATTTTCC  
Bs TCTCTTGTCTATCCAGCACTTAAAA 
Cs AAGGGATGAACATAAATGGGC 
Ds TGCTATCCAACGCTTCTTCC 
 
C.3. CCC-PRIMERS 
 
CHA1-CCC   
    Name                                             Sequence 
CHA1P1 GATTACCGATTCCTCTACTTTTGA 
CHA1T1 GTAAGCATCAACATATCCAAAACG 
CHA1 F AATTCAAAAGGACGGTAAAAGAT 
CHA1 R AAGGGATGAACATAAATGGGC 
  
INO1 D CTCATTTCAACGACTCTCTTTTTC 
 GCACTTTCTCGCATCTACCTCA 
    Name                                        Sequence 
CHA1 A GCGATGAGATAAGATAAAAGGGA 
 GATTACCGATTCCTCTACTTTTGA 
CHA1 B AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 C GGTGGAAACGAATGGATGTC 
 TCTTAGTGTTGTAACCCAAATGC 
CHA1 D GGAAGAAGCGTTGGATAGCAT 
 CGTTTTGGATATGTTGATGCTTAC 
    Name                                        Sequence 
CHA1 A GCGATGAGATAAGATAAAAGGGA 
 GATTACCGATTCCTCTACTTTTGA 
CHA1 B AATTCAAAAGGACGGTAAAAGAT 
 AAGGGATGAACATAAATGGGC 
CHA1 C GGTGGAAACGAATGGATGTC 
 TCTTAGTGTTGTAACCCAAATGC 
CHA1 D GGAAGAAGCGTTGGATAGCAT 
 CGTTTTGGATATGTTGATGCTTAC 
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 INO1-CCC 
    Name                                             Sequence 
INO1 P1 GAACCCGACAACAGAACAAGC 
INO1 T1 GTTGAGGTAGATGCGAGAAAGTG 
INO1  F GATATCCAGAATTTCAAAGAAGAAAAC 
INO1  R TATTCTGCGGTGAACCATTAATATAG 
 
 MET16-CCC 
    Name                                             Sequence 
MET16 P1 TTTGCTGGCCTTAGTTTTGATC 
MET16T1 GGAAGATGGAAGGGCAAGG 
INO1  F GATATCCAGAATTTCAAAGAAGAAAAC 
INO1  R TATTCTGCGGTGAACCATTAATATAG 
 
C.4. RT-PCR PRIMERS 
 
CHA1-RT-PCR 
    Name                                             Sequence 
CHA1 A AATTCAAAAGGACGGTAAAAGAT 
CHA1 B AAGGGATGAACATAAATGGGC 
18 S  F GGAATAATAGAATAGGACGTTTGG 
18 S R GTTAAGGTCTCGTTCGTTATCG 
 
MET16-RT-PCR 
    Name                                             Sequence 
MET16-A CATTTGGTTTGACTGGCTTGG 
MET16-B TCGTACTTGTCATCATCTTTCTCC 
18 S  F GGAATAATAGAATAGGACGTTTGG 
18 S R GTTAAGGTCTCGTTCGTTATCG 
 
INO1-RT PCR 
    Name                                             Sequence 
INO1 A GATATCCAGAATTTCAAAGAAGAAAAC 
INO1 B TATTCTGCGGTGAACCATTAATATAG 
18 S F GGAATAATAGAATAGGACGTTTGG 
18 S R GTTAAGGTCTCGTTCGTTATCG 
 
C.5. Strain-making primers  
    Name                                        Sequence 
5′ TFIIB-Myc-F2 TTGCTAATGGTGTAGTGTCTTTGGATAACTTACCGGGCGT
TGAAAAGAAACGGATCCCCGGGTTAATTAA 
3'TFIIB-Myc-R1 CACGAGTACCCGTGCTTCTTGTTCCTATAATTTACTGTTTT
ATCACTTCAGAATTCGAGCTCGTTTAAAC 
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5′F1-RNA14-Myc-tag 
 
TTTTAAATGATCAAGTAGAGATTCCAACAGTTGAGAGCAC
CAAGTCAGGTCGGATCCCCGGGTTAATTAA 
3′R1-RNA14- Myc-tag 
 
AGATGTGTTGGTATAAATATTCATATATACCTATTTATTAAC
GTAATGTTAGAATTCGAGCTCGTTTAAAC 
5'F1- PCF11-Myc-tag 
 
CTAATAGTGGCAAGGTCGGTTTGGATGACTTAAAGAAATT
GGTCACAAAACGGATCCCCGGGTTAATTAA 
3′R1- PCF11-Myc-tag TAATATAATATATAGTTATTAAATTTAAATGTATATATGCAG
TTCTGCTCGAATTCGAGCTCGTTTAAAC 
5' F2-RNA15-HA-tag 
 
CTATTTGGGACTTAAAACAAAAAGCATTAAGGGGAGAATTT
GGTGCATTTCGGATCCCCGGGTTAATTAA 
3'RNA15-HA-tag 
 
ATCATTGCGGAACCGCATTTTTTTTTTGTATTTTTGCCTCC
CTAGTTTCAGAATTCGAGCTCGTTTAAAC 
5′TFA2-TAP-C 
 
TTACTAACACTCATATGACCGGTATCTTGAAAGATTATTCC
CATAGAGTATCCATGGAAAAGAGAAG 
3'TFA2-TAP-C 
 
CAGTCTCTTTAACCTAATATGCAAACGAAAATGATTTAATC
AAAACAACCTACGACTCACTATAGGG 
5′TFG2-TAP-C 
 
GAGACGCGGAGGCTGACTTGGAAGATGAAATAGAAATGG
AAGATGTCGTTTCCATGGAAAAGAGAAG 
3'TFG2-TAP-C 
 
CTCAAGAAACTGCGTAAATATAAAATTAATGAAGAAAATCT
GATTGTCAATACGACTCACTATAGGG 
5′ CCL1-C-TAP 
 
AGTTGAATGGAGAAGATACTTCGTCCACCGTTGAGAAAAA
GCAAAAAACATCCATGGAAAAGAGAAG 
3' CCL1-C-TAP 
 
CTTAATCTATATATATATATAAAACAGAAACCTACGGTAAC
AGAGCTGTTTACGACTCACTATAGGG 
5′TRP1-KMX 
 
TATTGAGCACGTGAGTATACGTGATTAAGCACACAAAGGC
AGCTTGGAGTCAGCTGAAGCTTCGTACGC 
3'TRP1-KMX 
 
TGCAGGCAAGTGCACAAACAATACTTAAATAAATACTACTC
AGTAATAACGCATAGGCCACTAGTGGATCTG 
 
C.6. ScriptSeq Index PCR-GRO-Seq 
   Name                                        Sequence 
Index # 1 Index 1   5′-ATCACG-3′ 
Index # 6 Index 6   5′-GCCAAT-3′ 
Index # 12  Index 12  5′-CTTGTA-3′ 
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APPENDIX D: MEDIA 
YEAST EXTRACT-PEPTON-DEXTROSE (YPD) medium (1 liter) 
 
INOSITOL DROP-OUT MEDIUM (1 liter) 
Component         Quantity                 Notes 
Ammonium Sulfate 
 
          5 g  
Vitamin Stock  1 ml 
 
 Of 1000X stock solution 
Trace Elements Stock 1 ml 
 
 Of 1000X stock solution 
Salt Mix 1.7 g 
 
 
Inositol drop-out amino 
acid Mix 
230 mg 
 
 
Dextrose 20 g  100 ml of 20% stock-add after 
autoclaving 
 
 TRACE ELEMNTS STOCK (1000X; 100 ml)-FOR INOSITOL DROP-OUT MEDIA 
 Component Quantity                 Notes 
Yeast extract 10 g  
Peptone 20 g  
Dextrose 20 g  100 ml of 20% stock-add after 
autoclaving 
Agar 20 g  For plates only 
NaOH  1 pellet  For plates only 
Component Quantity                    Notes 
 
Boric acid 
 
              50mg  Autoclave 
 
 Store in a dark bottle at 4oC 
 
 
 
Copper sulfate 4 mg 
 
Potassium iodide                          10 mg 
 
Ferric chloride 20 mg 
 
Manganese sulfate                       40 mg 
 
Sodium molybdate       
        
20 mg 
 
Zinc sulfate                       40 mg 
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VITAMIN STOCK (1000X; 100 ml)- FOR INOSITOL DROP-OUT MEDIA 
 
 SALT MIX- FOR INOSITOL DROP-OUT MEDIA 
 
 AMINO ACID MIX- FOR INOSITOL DROP-OUT MEDIA 
Component         Quantity                Notes 
Biotin  2 mg 
 
 
 Autoclave 
 
 Store in a dark bottle at 4oC 
  
Calcium pantothenate                200 mg 
 
Folic acid                                           0.2 mg 
 
Niacin              40 mg 
 
β-Aminobenzoic acid                    20 mg 
 
Pyridoxine hydrochloride              40 mg 
 
Riboflavin                                           20 mg 
 
Thiamin hydrochloride                  40 mg 
 
Component Quantity  Notes 
 
Potassium phosphate monobasic    85 g  
 
Potassium phosphate dibasic          15 g  
 
Magnesium sulfate                           50 g  
 
Sodium chloride                               10 g  
 
Calcium chloride                              10 g  
 
Component Quantity   Notes 
 
Adenine hemisulfate                     40 mg 
 
  
 
Histidine 20 mg  
 
Leucine   60 mg  
 
Lysine 30 mg   
 
114 
 
 
 
 
 INOSITOL STOCK (100 X; 100 ml) 
Component Quantity                    Notes 
 
Inositol ( for plus inositol medium)      1 g  1 ml/ liter of inositol drop-out 
medium 
 
 
 METHIONINE DROP-OUT MEDIUM (1 liter) 
Component Quantity 
 
Notes 
Yeast nitrogenous base  6.7 g  without amino acids 
 
methionine drop-out mix 1 g  
 
Agar 20 g  For plates only 
 
NaOH 
 
1 pellet  For plates only 
Dextrose  20 g 
 
 100 ml of 20% stock-add after 
autoclaving 
 
  METHIONINE DROP-OUT MIX- FOR METHIONINE DROP-OUT MEDIA 
Component Quantity               Notes 
 
Adenine 2.5 g 
 
 
L-arginine 1.2 g 
 
 
L- asparatic acid 6.0 g 
 
 
L- glutamic acid 6.0 g 
 
 
L-Histidine 1.2 g 
 
 
L-leucine  3.6 g 
 
 
L-lysine 1.8 g 
 
 
Methionine     20 mg   
 
Tryptophan   40 mg  
 
Uracil     20 mg  
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L-phenylalanine 3.0 g 
 
 
L-tryptophan 2.4 g 
 
 
L-tyrosine 1.8 g 
 
 
L-valine 9.0 g 
 
 
Uracil 1.2 g 
 
 
 
  AMMONIUM SULFATE MEDIUM (1 liter)-FOR CHA1 RPRESSION 
Component      Quantity                    Notes 
 
 Yeast nitrogenous base        1.7 g  
 
 Without amino acids 
  Without ammonium sulfate 
Ammonium sulfate 5 g  
 
Amino acid mix 230 mg  
 
Dextrose        20 g 
 
 100 ml of 20% stock-add after 
autoclaving 
 
   SERINE/ THREONINE MEDIUM (1 liter)-FOR CHA1 ACTIVATION 
Component      Quantity                    Notes 
 
 Yeast nitrogenous base        1.7 g  
 
 Without amino acids 
  Without ammonium sulfate 
L-serine 1 g  
 
L-threonine  
 
1 g  
Amino acid mix 230 mg  
 
Dextrose       20 g 
 
 100 ml of 20% stock-add after 
autoclaving 
 
 
 
 AMINO ACID MIX FOR CHA1 MEDIA 
Component Quantity   Notes 
 
Adenine hemisulfate                     40 mg 
 
  
 
Histidine 20 mg  
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  TRYPTON DROP-OUT MEDIUM (1 liter) 
Component Quantity 
 
Notes 
Yeast nitrogenous base  6.7 g  without amino acids 
 
Trypton drop-out amino acid mix  1 g  
 
Agar 20 g  
 
NaOH 
 
1 pellet  
Dextrose  20 g 
 
 100 ml of 20% stock-add after 
autoclaving 
 
TRYPTON DROP-OUT MIX 
 
Leucine   60 mg  
 
Lysine 30 mg   
 
Methionine     20 mg   
 
Tryptophan   40 mg  
 
Uracil     20 mg  
 
Component Quatity  Notes 
 
Adenine 2.5 g   
 
L-arginine 1.2 g  
 
L- asparatic acid 6.0 g  
 
L- glutamic acid 6.0 g   
 
L-Histidine 1.2 g   
 
L-leucine  3.6 g   
 
L-lysine 1.8 g  
 
L-methionine 1.2 g  
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 G418 PLATES (KMX-MEDIUM) -1 liter 
 
 2XYT MEDIUM-1 liter 
 
 
 
 
 
 
L-phenylalanine 3.0 g  
 
L-tyrosine 1.8 g  
 
L-valine 9.0 g  
 
Uracil 1.2 g  
 
Component Quantity 
 
Notes 
Yeast nitrogenous base   10.0 g  without amino acids 
 
Peptone  20.0 g  
 
Agar 20. 0 g  
 
Dextrose   20 g 
 
 100 ml of 20% stock-add after 
autoclaving 
G418 
 
 1.0 ml  Of 400 mg/ml  
Component Quantity 
 
Notes 
Yeast extract   10.0 g  without amino acids 
 
Tryptone  16.0 g  
 
NaCl 5. 0 g  
 
Agar 
 
20.0 g  For plates only 
118 
 
 
 
                            APPENDIX E: BUFFERS AND SOLUTIONS 
 
STOCK SOLUTIONS 
Reagent Molarity/ concentration/ 
percentage 
                    Notes 
 
Tris-HCl- pH 8.0 1.0 M 
 
 Adjust  pH  using HCl 
EDTA  pH 7.0 to 8.0 0.5 M  Adjust pH using  NaOH 
 
NaCl 5.0 M  Autoclave 
 
KCl 2.0M  Autoclave 
 
SDS 10% 
 
 Filter sterilize 
CaCl2 1.0 M  Autoclave 
 
MgCl2 1.0  M  Autoclave 
 
PEG  (Mw 4000) 
 
50 %  Filter sterilize 
LiOAc 
 
1.0 M  Filter sterilize 
Glycine 2.5 M  Autoclave 
 
Ammounium acetate 
 
7.5 M  Autoclave 
NaOAc pH 5.2 3.0 M  Adjust pH using glacial 
acetic acid 
Glycerol 50 %  Autoclave 
 
Tergitol 10 %  Autoclave 
 
Triton X-100 10 %  Filter sterilize 
 
LiCl 5.0 M 
 
 Autoclave 
 
HEPES pH 7.9 1.0 M  Adjust the pH using 
KOH 
 Filter sterilize 
Sodium deoxycholate 10%  Filter sterilize 
 
KOH 10.0 M 
 
 
 Autoclave 
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AGAROSE GEL ELECTROPHORESIS BUFFER (1X TAE) 
Component Concentration                 Notes 
 
Tris-acetate 40 Mm  Autoclave 
 
0.5 M EDTA pH 8.0 1 mM EDTA  Autoclave 
 
 
 SOLUTIONS FOR YEAST GENOMIC DNA EXTRACTION 
  
SOLUTIONS FOR LiOAc/DMSO YEAST TRANSFORMATION 
Dextrose 20 %  Autoclave 
 
PMSF 100 mM 
 
 Don’t autoclave 
 Keep at 4oC 
Glycogen 20 mg/ ml  Filter sterilize 
 
DTT 1.0 M  Filter sterilize 
 
Ethedium  bromide 10.0 mg / ml  Don’t autoclave 
 Keep at 4oC 
Ammonium acetate 7.5 M  Autoclave  
 
TE 10X 
 
 100 mM Tris.HCl pH 8.0 
 10 mM EDTA 
TAE 
 
50 X  2.0 M Tris-acetate 
 50 mM EDTA 
TBS 
 
10X  100 mM Tris-HCl pH 8 
 2M NaCl 
Reagent Composition                  Notes 
Lysis buffer 2% Triton X-100 
100 mM NaCl 
10 mM Tris-HCl pH 8.0 
10 mM EDTA 
1% SDS 
 
Reagent Composition                  Notes 
LiAOAc buffer 0.1 M LiAOAc 
10 mM Tris-HCl(pH=8.0) 
1 mM EDTA 
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SOLUTIONS FOR PLASMID MINIPREP 
 
YEAST CELL WASH  
 
CHROMATIN IMMUNOPRECIPITATION (ChIP) BUFFERS AND SOLUTIONS 
 FA-LYSIS BUFFER   
PEG solution 50 % w/v PEG (M.W. = 
4000) 
0.1 LiAOAc 
10 mM Tris-HCl (pH=8.0) 
1 mM EDTA 
 Filter sterilize  
DMSO 100 %  
Solution Composition               Notes 
Solution I 50 mM Dex 
10 mM EDTA 
25 mM Tris-HCl pH 8.0 
 
Solution II 
 
0.1 N NaOH 
1% SDS 
 
Solution III 
 
 
30 ml 5M KOAc 
5.75 ml glacial HOAc 
14.25 ml H2O 
 Store at – 20 oC 
component Concentration               Notes 
Wash buffer I 1X  TBS  Autoclave 
Wash buffer II 1XTBS 
1%  Triton X-100 
 Autoclave 
Reagent Concentration Notes 
 
HEPES-KOH pH 7.9 50 mM 
 
 
 Store at -20 oC 
 
 
 
 
 
NaCl 
 
140 mM 
EDTA 
 
1 mM 
Triton X-100 
 
1 % 
Sodium Deoxycholate 
 
0.1 % 
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FA-LYSIS BUFFER + 500 mM NaCl  
Reagent Stock 
Concentration 
Volume added 
HEPES-KOH pH 7.9- 8.0 
 
50 mM  
 Store at - 20 
 
  
       
 
 
 
 
NaCl 
 
500 mM 
EDTA pH 8.0 
 
1 mM 
Triton X-100 
 
1 % 
Sodium Deoxycholate 
 
0.1 % 
PMSF 
 
1 mM 
SDS 
 
0.07 % 
 
ChIP WASH BUFFER  
Reagent 
 
Concentration Notes 
Tris-HCl pH 7.5 to 8 
 
10 mM  Store at -20 oC 
LiCl 
 
250 mM 
Triton X-100 
 
0.5 % 
EDTA pH 8.0 
 
1 mM 
Sodium Deoxycholate 
 
0.5 % 
SDS 
 
0.1 % 
 
ChIP ELUTION BUFFER  
PMSF 
 
1 mM 
SDS 
 
0.07 % 
Reagent Concentration Notes 
 
Tris-HCl pH 7.5 to 8.0 
 
50 mM  Store at room temperature 
122 
 
 
 
 
REVRESE TRANSCRIPTION PCR (RT-PCR) BUFFERS AND SOLUTIONS 
HIGH TE BUFFER 
Reagent Concentration Notes 
 
Tris-HCl pH 7.5 50 mM  Store at RT 
 
EDTA 20 mM  
 
 
RNA-LYSIS BUFFER 
 
CHROMOSOME CONFORMATION CAPTURE SOLUTION 
TM BUFFER 
 
TRANSCRIPTION RUN-ON ASSAY SOLUTIONS AND BUFFERS 
SDS 1 % 
 
EDTA pH 8.0 
 
10 mM 
Reagent Concentration Notes 
 
Tris-HCl pH 8.0 
 
80 mM  
CaCl2 
 
10 mM  
β-mercatoethanol 
 
10 mM  
VCR (Shake well) 
 
10 mM  
Component Concentration Notes 
 
Tris HCl pH 7.5- 8.0 
 
10 mM  
MgCl 2 
 
5 mM  
Reagent Composition Notes 
 
20X SSC 
3 M NaCL 
300mM Na3CitrateX2H2O 
 Adjust pH to 7.0 
using HCl 
Sarkosyl 10% 
 
 
Boiling solution 
 
0.4 N NaOH 
1 mM EDTA 
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IMMUNOPRECIPITATION ASSAY BUFFERS AND SOLUTIONS 
Hybridization 
solution 
0.5M potassium phosphate pH 7.2 
7%  SDS 
 
 
Membrane wash I 
 
0.1% SDS 
1% SSC 
 
 
Membrane wash II 
0.1% SDS 
0.1% SSC 
 
2.5 XRun-on buffer 
50 mM Tris-HCl pH 7.5 
500 mM KCl 
80 mM MgCl2 
5 mM DTT 
 
NTPs/RNase 
inhibitor mix 
 
10 mM each of CTP, ATP, and GTP 
300 units of RNase Inhibitor 
7 μl of [α-32P]-UTP (3000 Ci/mmol, 
10 μCi/μl 
 
TMN buffer 
10 mM Tris-HCl pH 7.5 
5 mM MgCl2 
100 mM NaCl 
 
NaOAc/HOAc mix 
 
0.3 M sodium acetate pH 5.2 
0.5 μl of glacial acetic acid 
 
 
LETS buffer 
 
0.1 M LiCl 
0.2% SDS 
10 mM EDTA 
10 mM Tris-HCl pH 7.5 
 
Component Concentration Notes 
IP lysis buffer 10% glycerol 
20 mM Tris-HCl pH 8.0 
50 mM KCl 
0.5 mM EDTA 
1 mM MgCl2 
0.1% TritonX-100 
1 mM PMSF (add directly before 
use) 
 Autoclave 
 Keep at 4oC 
30% Acrylamide:Bis 
Solution 
1 %  Bisacrylamide 
29%  Acrylamide 
 
 
4% stacking gel 
 
125 mM Tris-Cl, pH 6.8 
0.1% SDS 
5% Acrylamid  mix 
0.1 Ammonium persulfate 
 
 Keep at 4oC 
Electrode buffer 
 
25 mM tris 
250 mM glycine 
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0.1 SDS 
5X laemeli buffer 250 mM Tris HCl pH 6.8 
50 % Glycerol 
10% SDS 
2.8 M β-mercaptoethanol 
0.1% Bromophenol blue 
 
Transfer Buffer 20% Methanol 
24 mM Tris-base 
192 mM Glycine 
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In budding yeast, as in higher eukaryotes, transcription of protein coding genes is 
executed by a highly specialized, conserved polymerase called RNA polymerase II 
(RNAPII). The transcription cycle of RNAPII has four major steps: initiation, elongation, 
termination, and reinitiation. The successful accomplishment of each of these steps 
requires a number of accessory factors. Many of these factors operate at multiple steps 
in the transcription cycle. The major focus of this study was to examine the function of 
Clp1, which is an RNA processing factor operating at the 3′ end of genes, in the 
transcription cycle. Clp1 is one of the four subunits of the CFIA 3′ end processing 
complex. It is the least investigated CFIA subunit. The role of the other three subunits of 
the CFIA complex in 3' end processing and termination of transcription is well 
documented.  
Here we investigate the role of Clp1 in the initiation as well as the termination of 
transcription. We used a temperature-sensitive mutant of Clp1 to assess its function. 
We demonstrated a direct role for this factor in the termination of transcription of CHA1. 
We used three different approaches; TRO assay, RNAPII-ChIP assay, and strand 
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specific RT-PCR, to demonstrate the termination function of Clp1. In addition, we 
showed that Clp1 is also involved in the early steps of the transcription. Our results 
strongly suggest that Clp1 participates in promoter-associated transcription. We provide 
multiple lines of evidence in support of a role for Clp1 at the 5′ end of genes. First, the 
presence of Clp1 in the vicinity of the promoter region implies its involvement early in 
the transcription cycle. Second, the decrease in RNAPII density near the promoter 
without a parallel decrease in the level of the GTFs suggested a role for Clp1 in 
reinitiation of transcription. Third, an increase in 5' initiated antisense divergent 
transcripts in the Clp1 mutant supports a role for the factor in providing directionality to 
the promoter-bound polymerase. To assess the generality of the observed functions of 
Clp1, we investigated the role of Clp1 in the transcription cycle on a genomewide scale 
using GRO-Seq approach. Our results show that the number of transcriptionally active 
genes decreased by at least two-fold in the clp1mutant. The GRO-Seq results strongly 
suggest a genomewide function for Clp1 in the termination of transcription, and indicate 
that Clp1 is required for the pausing of RNAPII that is a pre-requisite for the termination 
of transcription. We also observed a dramatic increase in 3' initiated antisense 
transcription in the absence of a functional Clp1 protein.  
Using the chromosome conformation capture approach, CCC, we observed a 
role for Clp1 in gene loop formation. We found a strong correlation between the Clp1 
function in gene looping, and its role in promoter-associated transcription which implies 
gene looping as the means through which this factor is exerting its functions at the 5′ 
end of genes.   
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